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Snail transcription factors up-regulate the expression of pro-inflammatory genes
in keratinocytes
J.G. Lyons1,2,3, V. Patel3, N. Roue1,2, G.M. Halliday1 and J. S. Gutkind3
1Dermatology Research Labs, University of Sydney; and 2Sydney Head & Neck Cancer Institute,
RPA Hospital, Camperdown NSW, Australia; and 3Oral and Pharyngeal Cancer Branch, NIDCR,
NIH, Bethesda MD, USA
Background: The Snail family of zinc finger transcription repressors is known to induce an
epithelial-mesenchymal transition in epithelial cells and are over-expressed in squamous cell
carcinomas. A prominent target of Snail is E-cadherin, a cell-cell adhesion protein that is
important in maintaining polarity and a differentiated epithelial phenotype. We are interested in
identifying other target genes, particularly those that are important to EMT and the progression of
squamous cell carcinomas.
Method: A chimeric gene was made by fusing human Snail-1 at its C-terminus to ERT2, a mutant
form of the human estrogen receptor that is inducible by tamoxifen and stably transfected clones
of human keratinocytes of both head & neck and skin origin were selected. We screened
tamoxifen treated cells for Snail regulated genes using cDNA microarrays and validated them as
genuine targets using quantitative PCR and immunoassay methods.
Results: As well as down-regulating the expression of several epithelial cell-cell adhesion protein-
encoding genes, other genes important in the terminal differentiation of keratinocytes were
demonstrated to be down-regulated by Snail-1. Among the genes that were up-regulated by Snail-
1 was a cohort of genes with roles in inflammation. In biological assays, Snail-1 enhances
migration of leukocytes.
Conclusion: Inflammation is associated with progression of benign lesions to squamous cell
carcinomas, and we postulate that Snail expression in the keratinocytes drives this process by
secreting pro-inflammatory molecules that recruit and activate leukocytes.
Diagnosis of melanoma by 4-colour fish
A.L. Morey1, S. McCarthy2 and R. Scolyer2
1Anatomical Pathology, St Vincent’s Hospital Sydney; 2Anatomical Pathology, RPA Hospital,
Sydney and Sydney Melanoma Unit
Background: Histopathology is usually regarded as the gold standard for the diagnosis of
pigmented skin tumours. However, a small subgroup of melanocytic tumours remain
diagnostically equivocal even by experts. Previous studies by Bastian et al. (2003) using
comparative genomic hybridisation (CGH) identified a group of chromosomal gains and losses
that were present in melanomas but absent in benign naevi. A multi-colour FISH assay developed
by Abbott-Vysis incorporates probes for a subset of these loci (6p, 6q, cep6 and 11q). We have
been involved in a multi-centre evaluation of this assay, with the aim of documenting its efficacy
in distinguishing histopathologically unequivocal benign from unequivocal malignant melano-
cytic tumours prior to assessing its potential value in equivocal tumours.
Methods: The multi-colour Abbott-Vysis FISH assay was used to assess 20 histopathologically
unequivocal benign naevi and 20 unequivocal melanomas (10 primary and 10 metastatic). The
assay employs standard paraffin FISH techniques and equipment, however, interpretation requires
correlation with H&E appearances and expertise in the histopathology of melanocytic tumours.
Results: Specificity of the assay was 95% using the cut-off values for 4 parameters proposed by the
manufacturer, with 1 of 20 benign naevi being borderline positive by one parameter. Sensitivity
among 20 melanomas was 85%, with 12 of the 17 FISH-positive cases being scored positive by
more than one parameter. The commonest abnormality was gain of 6p (present in 55%), followed
by gain of 11q (50%) and loss of 6q (50%). Gain of 6q was rare (10%).
Conclusions: The assay holds promise for the diagnosis of difficult melanocytic tumours, but may
also assist in the molecular subclassification of melanomas, which are not a homogenous group of
tumours.
Reference
(1) Bastian BC, Olshen AB, LeBoit PE, et al. Classifying melanocytic tumours based on DNA
copy number changes. Am J Pathol 2003; 163:1 765–70.
Novel and selective anti-cancer agents against melanoma: a new therapeutic
strategy
D.R. Richardson Department of Pathology and Bosch Institute, University of Sydney, Sydney,
New South Wales, Australia 2006.
Background: Novel chemotherapeutics with marked and selective anti-tumor activity are essential
to develop, particularly those that can overcome resistance to established therapies. Iron (Fe) is
critical for cell cycle progression and DNA synthesis and potentially represents a novel molecular
target for the design of new anti-cancer agents. The aim of this current study was to evaluate the anti-
tumor activity and Fe chelation efficacy of a new class of Fe chelators using human tumors.
Method: In this investigation, the ligands showed broad anti-tumor activity and could overcome
resistance to established anti-tumor agents. The in-vivo efficacy of the most effective chelator
identified, Dp44mT, was assessed using a panel of human xenografts in nude mice.
Results: After 7 weeks, net growth of a melanoma xenograft in Dp44mT-treated mice was only
8% of that in mice treated with vehicle. In addition, no differences in these latter animals were
found in hematological indices between Dp44mT-treated mice and controls. No marked systemic
Fe-depletion was observed comparing Dp44mT- and vehicle-treated mice, probably due to the
very low doses required to induce anti-cancer activity. Dp44mT caused up-regulation of the Fe-
responsive tumor growth and metastasis suppressor, Ndrg1, in the tumor but not the liver,
indicating a potential mechanism of selective anti-cancer activity.
Conclusions: These results indicate that the novel Fe chelators have potent and broad anti-tumor
activity and can overcome resistance to established chemotherapeutics due to their unique
mechanism of action.
Reference
(1) Whitnall, M., Howard, J. Ponka, P. and Richardson, D.R. (2006) A class of iron chelators
with a wide spectrum of potent anti-tumor activity that overcome resistance to
chemotherapeutics. Proc. Natl. Acad. Sci. USA 103: 14901–6.
Hotspot mutation of the Brm gene in cutaneous squamous cell and basal cell
carcinomas
F. J. Moloney, J. G. Lyons, V. Bock, X.X. Huang, M. Bugeja and G. M. Halliday Dermatology,
Melanoma and Skin Cancer Research Institute, Sydney Cancer Centre, University of Sydney at
Royal Prince Alfred Hospital, Camperdown, NSW, Australia
Background: Chromosome 9p, a high frequency site for loss of heterozygosity in non-melanoma
skin cancer, contains the Brahma (Brm) gene. Brm protein is a catalytic ATPase subunit of the
SWI/SNF chromatin-remodelling complex, a key regulator of gene expression. There is strong
evidence in multiple tissue types other than skin cancer demonstrating a tumour suppressor role
for the Brm subunit however to date studies of primary tumors have failed to demonstrate
mutations in Brm.
Method: 10 squamous cell carcinoma (SCC), six basal cell carcinoma (BCC), 11 actinic keratosis
(AK), two keratoacanthoma and 10 normal skin samples, five from sun-exposed and five non
sun–exposed sites from 27 Caucasian patients were screened for sequence variants in three Brm
coding exons and intron-exon junctions using denaturing high performance liquid chromato-
graphy followed by forward and reverse sequencing of PCR products. Blood samples were drawn
for matched germline DNA.
Results: The same single-base substitution occurred in two of six BCC’s and in one of ten SCC’s,
all from sun-exposed sites in elderly Caucasian males. No mutation was present on sequencing of
matched germline DNA indicating that this mutation had been acquired somatically. This G:C to
T:A transversion results in a substitution of glutamine by lysine in 17% of studied non-melanoma
skin cancers but was not present in AKs or normal skin.
Conclusion: This report demonstrates a previously unidentified somatic mutation of tumour
suppressor gene, Brm. The observed GC – TA transversion, typical of mutations induced by
oxidative UVA damage, occurred exclusively in non-melanoma skin cancers on UV-exposed
sites. This suggests that Brm may be a tumour suppressor gene for skin cancer.
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Role of hair follicle stem cells in wound healing
Ito M.I., Yang Z., Andl T.,Cui C., Kim N., Millar S.E. and Costarelis G.
Over 15 years ago, we proposed that quiescent keratinocytes in the hair follicle bulge were
epithelial stem cells important for hair follicle cycling, epidermal renewal, wound healing and
carcinogenesis. Since that time, we identified cytokeratin 15 (K15) expression as a marker for
these cells and developed several transgenic mouse models using the (K15 expression as a marker
for these cells and developed several transgenic mouse models using the K15 promoter to further
study the bulge cells. Using K15-EGFP mice, we isolated bulge cells and demonstrated that they
possessed an epithelial stem cell phenotype of quiescence, high proliferative potential and
multipotency. We also characterized the cells at the molecular level using microarrays and
identified approximately 150 differentially expressed genes in these cells. Through genetic lineage
analysis using an inducible K15-CrePR; R26R biogenic mouse, we showed that bulge cells generate
all of the epithelial lineages within the lower anlagen hair follicle. However, ablation of bulge cells
using K15-thymidine kinas mice resulted in permanent hair loss but survival of the epidermis. Over
a prolonged period, bulge cells did not contribute to epidermal homeostasis, but in response to
wounding bulge cell progeny rapidly moved into the wound area to assist in reepithelialisation.
Bulge derived cells did not persist in the epidermis indicating that epidermal stem cells and hair
follicle stem cells are distinct populations each with self renewing capabilities.
HLA-G expression in normal human hair follicles and skin
Hope Dinh1,2, Katja Meyer3, Rodney Sinclair1, James McCluskey2 and Ralf Paus3
1Department of Dermatology, St Vincent’s Hospital, Melbourne, Victoria, Australia; 2Department
of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia and
3Department of Dermatology, University Hospital Schleswig-Holstein, Luebeck, Germany
Background: The hair follicle (HF) is one of the few sites of immune privilege (IP) in mammalian
tissue. Non-classical class I major histocompatibility complex (MHC) expression is thought to
contribute in-part to the maintenance of IP. In particular, HLA-G expression has been identified in
other immunoprivileged tissues. In addition, murine hair follicles express the Qa-2 molecule
which is considered the functional homolog of HLA-G. We examined for HLA-G expression in
human HFs and skin using RT-PCR and immunohistochemistry techniques.
Method: Scalp skin from 5 males undergoing routine cosmetic surgery was collected and HF units
were microdissected out. Expression of HLA-G was determined by HLA-G primer-specific RT-
PCR of follicular units and immunohistochemistry (IHC) of scalp skin. We used the JEG-3 (human
choriocarcinoma) cell line, which ubiquitously expresses HLA-G as a positive control.
Results: Of the 7 isoforms of HLA-G we found HLA-G3 and HLA-G4 transcript expression in
normal human HFs by RT-PCR. Using the murine anti-HLA-G monoclonal antibodies –MEM-G/
01 and 4H84 we found positive HLA-G expression on cryosections of normal scalp skin and HFs
by IHC. Interestingly, HLA-G expression in the epidermis was also localised to MHC-II and CD1a
expressing dendritic cells of the skin.
Conclusion: Follicular HLA-G expression may contribute to the maintenance of IP in normal
human HFs. HLA-G expression by epidermal Langerhans cells may contribute to their possible
tolerogenic role in the epidermis. Studies on HLA-G expression by HFs in disease states of
alopecia areata and cicatricial alopecia are in progress.
Porous films allow live human keratinocyte delivery and aid wound healing in
model mice
James R. McMillan1,2, Masaru Tanaka2, Masashi Akiyama1, Heather A. Long1, Hongjiang Qiao1,2,
Yuki Miyamura1, Sadaki Yamamoto2, Riichiro Abe1, Kazuo Kodama1, Masatsugu Shimomura2
and Hiroshi Shimizu1.
1Department of Dermatology, Graduate School of Medicine and 2Creative Research Initiative
Sousei, Faculty of Science, Hokkaido University, Sapporo, Japan
Background: We have previously demonstrated that self-organized patterned porous poly-
(epsilon-calprolactone) films with regularly spaced, controlled pore sizes provide adhesion and
support for cultured human keratinocytes and dermal fibroblasts.
Method:We determined the effects of applying various sized porous films (n¼ 3 mice per treatment)
on to 4mm punch biopsy wounded Balb C/SCID mice to assess wound healing response.
Results: Films with pores ranging in size from 3–20 microns, elicited a mild lymphocytic and
foreign body perifollicular immune response and increased dermal thickening, regardless of pore
size but this treatment failed to significantly improve wound healing time or increase wound
closure rates. By 21 days after wounding the porous film grafts had become fully biodegraded
within the wounded dermal tissue. Furthermore, we assessed the proof of principle that live
cultured cells (keratinocytes, fibroblasts or in combination) can be delivered into model SCID
mouse wounds using porous films. Human cells (15,000 or 30,000 cells/mm2 fibroblasts or
keratinocytes) were subconfluently cultured on 3 micron (for keratinocyte or cell combinations)
or 5 micron (fibroblasts alone) porous films. These cell/film combinations were then transplanted
onto wounded mice and wounding/vascularization quantitatively assessed. Fibroblasts alone or in
combination with low density seeded keratinocytes failed to significantly improve wound
healing. However, transplanted cells were readily detected using anti-human HLA antibodies in
wounded SCID (but not Balb C) mouse skin 21 days after treatment, when the wounds had
completely healed. Only high density (30,000 cells/mm2) seeded keratinocytes with or without
films improved wounding but without altering dermal vascularization. These keratinocytes
expressed intrinsic immune-related factors including beta defensins and other differentiation-
specific markers of keratinization and cell cohesion.
Conclusions: Taken together, our data demonstrate for the first time the feasibility of using porous
films to deliver live cells into wounds as part of our aim to utilize cell therapy to improve the
wound healing response.
Hair follicle methylation of the androgen receptor gene in male pattern baldness
J. Cobb1, L. Yip1,2, N. Wong3, S. Harrap1 and J. Ellis1,3
1Department of Physiology, University of Melbourne; 2Department of Dermatology, St Vincent’s
Hopsital, Melbourne, and 3Murdoch Childrens Research Institute, Melbourne
Background: The association of the Androgen Receptor gene (AR) and Male Pattern Baldness
(MPB) has been well documented since our original finding in 2001,1 with three subsequent
independent studies validating the association. It would appear that this gene confers strong risk
of developing hair loss, accounting for up to 40% of heritability.2. We are investigating several
types of genetic variation in the region, including the epigenetic control of AR. The level of
expression of genes can be modulated in specific tissues via methylation of key sequences known
as CpG islands. Increased AR gene expression has been identified in balding (eg vertex) compared
to non-balding (occipital) regions in the same individual, and the lower occipital expression of AR
may contribute to retention of hair in this region. We therefore hypothesised that in hair follicles
from occipital regions of MPB scalp the AR is more highly methylated, and thus less highly
expressed than in vertex hairs. It is known that AR is expressed in both dermal papilla (DP) and
outer root sheath (ORS) but is maximally expressed in DP suggesting this is a key region to
investigate. Access to DP samples requires skin biopsy or other surgical specimens. However, if
patterns of AR methylation are similar in the ORS and DP, then the ORS can be obtained from
plucked hairs and would provide an easier means to infer methylation in the DP. Thus, the first
aim of our study was to compare AR methylation patterns between ORS and DP obtained from
the same follicles in men with MPB.
Methods: We are collecting follicles from hair transplant surgeons and dissecting DP and ORS.
We are using bisulfite sequencing methods to determine the pattern of methylation within the AR
CpG islands.
Results: Preliminary data indicates the methylation in the promoter of AR is in fact different
between the DP and ORS cells.
Conclusion: It appears likely that DP will be needed to test the hypothesis that increased
methylation reduces AR expression and protects the occipital scalp from hair loss.
References
(1) Ellis, J.A., Stebbing, M. et al. (2001). ‘‘Polymorphism of the androgen receptor gene is
associated with male pattern baldness.’’ J Invest Dermatol 116(3): 452–5.
(2) Hillmer, A. M., S. Hanneken, et al. (2005). ‘‘Genetic variation in the human androgen
receptor gene is the major determinant of common early-onset androgenetic alopecia.’’ Am J
Hum Genet 77(1): 140–8.
2910 Journal of Investigative Dermatology (2009), Volume 129
Abstracts
Quality of life evaluation in epidermolysis bullosa: development and results of the
QOLEB questionnaire
J. Frew1, L. Martin2 and D.F. Murrell1,2
1University of New South Wales, Sydney, Australia and 2Department of Dermatology, St George
Hospital, Kogarah, Sydney, Australia
Background: Epidermolysis Bullosa (EB) has a profound effect on quality of life; however generic
QOL assessments are poor indicators of the impact of EB.
Method: Open, non-structured interviews were conducted with 26 EB patients, along with 33
family members and 11 health professionals (70 individuals) were conducted for item generation.
A pilot questionnaire was compiled, refined and the final questionnaire was assessed for
repeatability and validity. Discriminative validity was assessed by differences in scores between
EB subtypes. Content validity was assessed by expert ranking of items in terms of importance.
Construct validity was evaluated by correlation with existing QOL tools. Test-retest repeatability
and internal consistency were also evaluated.
Results: The QOLEB was able to accurately distinguish different EB subtypes, and correlated
highly with existing QOL instruments. It also demonstrated the high impact EB has upon QOL,
particularly with regards to Recessive Dystrophic EB.
Conclusion: The QOLEB is the first EB-Specific QOL measurement tool, which is a valid and
reliable measurement tool for the quantification of QOL in patients with various subtypes of EB. In
addition, the QOLEB has potential as a sensitive instrument to monitor QOL, and to identify
dimensions of QOL as targets for interventions and research.
Nicotinamide protection of skin immunity may be mediated by prevention of UV-
induced cellular energy loss
Joohong Park1, Gary M. Halliday1 and Diona L. Damian1
1Department of Dermatology, Melanoma and Skin Cancer Research Institute, Sydney Cancer
Centre, University of Sydney, Royal Prince Alfred Hospital, Camperdown, New South Wales,
Australia
UV radiation-induced immunosuppression augments the development of skin cancers, which are
the most common form of malignancy in Caucasian populations. The incidence of skin cancer
continues to increase despite increased use of sunscreens, which are less effective at preventing
immunosuppression than sunburn. Topical or oral nicotinamide prevents UV immunosuppres-
sion, and shows promise as a non-toxic and inexpensive agent which could be used to help
reduce premalignant and malignant skin lesions. Previously, gene chip microarrays suggested that
nicotinamide’s mechanisms of protection may include alterations in complement, energy
metabolism and apoptosis pathways. From the microarray results, more than 20 genes were
selected and further analysed by quantitative real time RT-PCR using human skin biopsies as well
as the HaCaT keratinocyte cell line. The genes selected showed the same directionality as the
microarray results, and the genes TP53 (apoptosis pathway) and succinic dehydrogenase (SDH)
(electron transport chain pathway) were significantly upregulated in the presence of
nicotinamide. Using fluorescence microscopy to detect superoxide and hydrogen peroxide, we
found that nicotinamide did not reduce UV-induced reactive oxygen species generation. In
contrast, the amount of intracellular ATP (an indicator of mitochondrial function and effectiveness
of cellular oxidative phosphorylation) was determined by luciferase assay in the presence of
nicotinamide after solar-simulated (ss)UV irradiation (4 J/cm2). Nicotinamide prevented ssUV-
induced ATP depletion. These results suggest that nicotinamide exerts its protective effects by
preventing UV-induced loss of cellular energy, which would enhance the ability of skin cells to
repair UV-induced damage, thus preventing immunosuppression.
Baldness and the androgen receptor – where are we and where are we going?
J. Ellis1,2, J. Cobb1, L. Yip1,3 and S. Harrap1
1Department of Physiology, University of Melbourne, Victoria 3010; 2Murdoch Childrens
Research Institute, Flemington Road, Parkville, Victoria 3052 and 3Department of Dermatology,
St Vincent’s Hospital Melbourne, Fitzroy, Victoria 3065.
Background: The association between the gene encoding the Androgen Receptor (AR) and male
pattern baldness (MPB) is now well established. Since we first published on the association in
20011, three independent studies have replicated the finding, a hallmark of reliability in complex
disease association analyses. Seven years on, we are still unclear as to the mechanism by which
variants of AR act to cause hair loss. AR appears to be more highly expressed in balding follicles,
which suggests that an increase in gene expression is responsible. In an effort to uncover the cause
of this increased expression we are examining AR from a number of perspectives.
Methods: Firstly, we have examined AR copy number variation (CNV), a newly described form of
common human sequence variation in which stretches of the genome are duplicated/deleted, to
test the hypothesis that important regulatory sequences of AR are duplicated in balding scalp
causing an increase in expression. Secondly, we are examining the non-coding sequences
surrounding AR for high sequence conservation across species that might suggest functional
importance relevant to gene regulation, and are searching for relevant sequence variation within
these regions. Thirdly, as described in the abstract by Cobb et al, we are looking for differences in
epigenetic methylation patterns of the AR promoter between balding and non-balding hair
follicles that might affect gene regulation.
Results: (1) We found no evidence for a role of AR CNV in MPB. (2) We have identified a highly
conserved region of the upstream non-coding region of AR that contains a common sequence
variant and are currently testing the region for regulatory ability in the presence and absence of
the sequence variant. 3) Progress with methylation analyses is described in the abstract by Cobb
et al.
Conclusion: There are various mechanisms through which differences in AR expression levels
may exist between balding and non- balding scalps. Our investigations are considering a number
of these possibilities. We have eliminated CNV as a mechanism, and our analyses of non-coding
sequence variation and methylation differences continue with earnest, with promising
preliminary findings.
Reference
(1) Ellis JA, et al. (2001). ‘‘Polymorphism of the androgen receptor gene is associated with male
pattern baldness.’’ J Invest Dermatol 116(3): 452–5.
Migratory dermal dendritic cells act as rapid sensors of protozoan parasites
L. G. Ng1,2, A. Hsu3, M. A. Mandel4, C. Hoeller1, P. Mrass1, A Iparraguirre1, L. L. Cavanagh1,2, S.
Berverley4, P. Scott3 and W. Weninger1,2,5
1The Wistar Institute, Philadelphia, PA 19104, USA; 2The Centenary Institute for Cancer Medicine
and Cell Biology, Newtown, NSW 2042, Australia; 3Department of Pathobiology, School of
Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; 4Department of
Molecular Microbiology, Washington University School of Medicine, St Louis, MS 63110, USA
and 5Department of Dermatology, University of Sydney, Camperdown NSW 2050, Australia
Background: Skin dendritic cells (DC) play a crucial role in recognizing pathogens and inducing
adaptive immune responses. However, we have a poor understanding of the spatio-temporal
regulation of their behaviour during homeostatic and pathological conditions. The principal aim
of this study is to employ a newly developed approach, i.e. intravital two-photon microscopy (2P-
IVM), to visualize DC within their natural microenvironment. We propose to investigate how
these cells behave in the steady-state and in response to an important pathogen, Leishmania
major (L. major).
Method: To visualize the behaviour of langerhans cells (LC) and dermal dendritic cells (DDC), we
made use of CD11c-YFP mice, in which DC express high levels of cytoplasmic YFP.
Anaesthetized mice were placed onto a custom-built stage to position the ear on a small metal
platform for 2P imaging. 2P imaging was performed on a Prairie Technology Ultima System
attached to an Olympus BX-51 fixed stage microscope equipped with water immersion objective.
For Leishmania major inoculation, 1–2 105 stationary phase promastigotes in 1.5ml of saline
solution were injected intradermally using a 35 gauge Hamilton syringe.
Results: We observed that under homeostatic conditions, DDC were highly motile, continuously
crawling through the interstitial space in a Gai coupled receptor dependent manner. However,
within minutes after intradermal delivery of the protozoan parasite Leishmania major, DDC
became immobile and parasites were taken up by the extension of highly dynamic pseudopods
from the DDC.
Conclusion: These results uncover a unique migratory tissue surveillance program of DDC, and
define the intricate dynamics and microenvironmental context of DC-parasite interplay during the
earliest phase of cutaneous host defense.
www.jidonline.org 2911
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Analysis of aromatase gene (CYP19A1) polymorphisms in female pattern hair loss
L. Yip1,3, D. Irwin2, R. Sinclair1, S. Harrap3 and J. Ellis3,4
1Department of Dermatology, St Vincent’s Hospital Melbourne; 2Sequenom, Brisbane;
3Department of Physiology, The University of Melbourne and 4Murdoch Childrens Research
Institute, Melbourne
Background: Female pattern hair loss (FPHL) is a polygenic condition with an unproven hormonal
basis. Aromatase converts testosterone to estrogen and therefore the aromatase gene, CYP19A1, is
a plausible candidate relevant to the androgen-mediated pathway involved in androgenetic
alopecia. Using a candidate gene approach, this case-control genetic association study aims to
determine if there is a causal relationship between CYP19A1 with the phenotypes of FPHL.
Method: Tag single nucleotide polymorphisms (SNPs) in and around CYP19A1 that comprehen-
sively capture genotypic information of the entire gene region were selected for analysis using
The International HapMap database. SNP genotyping was performed for 484 cases and 471
controls using iPLEXs Gold single base primer extension of multiplex polymerase chain reaction
(PCR) products on the Sequenom MassARRAYs platform. Allele and genotype frequencies of
SNPs between cases and controls were analysed using w2-tests and permutation testing.
Results: 45 out of 61 tag SNPs on CYP19A1 have been analysed to date. Two CYP19A1 SNPs,
rs16964189 and rs4646, were found to be marginally associated with FPHL (p¼0.01 and
p¼ 0.04, respectively). Genotyping is ongoing for the remaining 16 SNPs.
Conclusion: The SNPs, rs16964189 and rs4646, are marginally associated with FPHL, suggesting
that these genetic variants may have a modest contribution to the steroid-mediated pathways
involved in FPHL. Associations with rs4646 have been previously reported with increased
efficacy of aromatase inhibitor treatment in breast cancers and a less aggressive status of breast
cancers.
Staphylococcus epidermidis: the cause of increased cathelicidins in rosacea?
M Whitfeld,1,2 and N Gunasingam1,2
1Department of Dermatology, St Vincent’s Hospital, Sydney, and 2The Skin & Cancer Foundation,
Sydney
Background: Rosacea is a common inflammatory skin disease consisting of facial flushing, t
elangiectasia, papules and pustules. Sometimes rhinophyma and ocular disease also occur. One
recent theory is that cathelicidin; found in increased levels in the skin of people with rosacea may
be playing a role. Cathellcidins are known for their role in protection of the host principally from
bacterial infections, but also for their role in promoting an inflammatory response.
Cathelicidin is secreted as a proprotein named CAP 18, which is biologically inactive.
Stratum Corneum Tryptic Enzyme (SCTE) is a serine protease required to convert CAP 18 to
cathelicidin. Yamasaki showed that the main cathelicidin peptide produced in persons with
rosacea are a 37 amino acid peptide (LL-37) as well as another peptide FA-29, which are both
found in rosacea skin, but not in normal skin. They showed that both these peptides, as well as
injection of SCTE into the skin produced rosacea-like inflammation in mice.
Staphylococcus epidermidis is a bacteria regarded by many as simply a commensal on the skin,
but is now recognised as being an important bacteria, in causing infection in orthopaedic
prosthetic surgery, ocular surgery, central venous and other catheter lines, as well as being an
important pathogen in neonatal intensive care units. The virulence of the bacteria appears to be
related to the strain of bacteria involved.
Hypothesis: We propose that Staphylococcus epidermidis is the trigger for cathelicidin increase,
and that it works by increasing the expression of SCTE.
In a study performed in 2006 we showed there was a statistically significant difference in the type
of bacteria isolated from the pustules of rosacea cases compared with the bacteria isolated from
the surrounding skin of the same case (P ¼ 0.001). Nine out of fifteen pustule lesions cultured
pure growth of Staphylococcus epidermidis, whereas none of the skin swabs taken from the
surrounding skin showed a pure growth. We propose that Staph epidermidis is the cause for the
pustules of rosacea, growing in the altered environment of vascular dilatation associated with
prolonged flushing, and that the canthelicidins are expressed in response to this growth.
A role for snail transcription factors in impeding terminal differentiation and
enhancing tumorigenicity of keratinocytes.
N. Roue1,2, S. Otsuka1,2, G.M. Halliday1 and J.G. Lyons1,2
1Dermatology Research Labs, University of Sydney and 2Sydney Head & Neck Cancer Institute,
RPA Hospital, Camperdown NSW, Australia
Background: Squamous cell carcinomas (SCCs) are characterised by an impaired ability to
undergo terminal differentiation, which contributes to their increased proliferative potential. The
Snail family of zinc finger transcription repressors, are known to induce an epithelial-
mesenchymal transition in epithelial cells and are over-expressed in squamous cell carcinomas.
We have shown that Snails down-regulate several genes that have been implicated as having roles
in terminal differentiation. The aim of the present study was to determine what effects Snail
expression in keratinocytes has on terminal differentiation and tumorigenesis.
Method: HN13, a non-tumorigenic keratinocyte cell line derived from a human tongue SCC, was
virally transformed with Snail-expressing or control viral vectors. Its ability to terminally
differentiate was examined in long-term cell culture and its ability to form tumours was tested by
intradermal injection in immunodeficient nude mice.
Results: HN13 cells terminally differentiated in culture, forming cornified squames that were shed
into the culture supernatant. The expression of Snail inhibited this process, particularly at the
stage of desquamation. The expression of Snail was not sufficient to confer tumorigenicity on
HN13 cells. However, Snail cooperated with oncogenic H-ras to form faster growing tumours.
Conclusion: The ability of Snail to enhance SCC formation might be related to its ability to impede
terminal differentiation. Snail expression might play a role in uncontrolled growth of SCCs, as
well as enhancing their invasiveness though epithelial-mesenchymal transitions.
E2F7 exhibits both tumour suppressive and oncogenic activities in human
keratinocytes
Nicholas Saunders1, Alison Dahler1, Danny Rickwood1, Anthony Griffin2, Geoffrey Strutton3 and
Liliana Endo-Munoz1
1Diamantina Institute for Cancer, Immunology & Metabolic Medicine, University of Queensland,
Princess Alexandra Hospital, Queensland, Australia; 2Department of Surgery, Princess Alexandra
Hospital, Queensland Australia and 3Department of Pathology, Princess Alexandra Hospital,
Queensland, Australia
Background:We have previously shown that inhibition of E2F activity is essential for the initiation
of squamous differentiation (1,2). For this reason, we postulated that endogenous inhibitors of E2F
may exist that are involved in the initiation of squamous differentiation. In the present study we
examine the potential role of E2F7 in regulating E2F-dependent functions in human keratinocytes
(proliferation, differentiation and apoptosis).
Results: We found that E2F7b was the most highly expressed splice variant of E2F7 whose
expression was restricted primarily to proliferating keratinocytes. In a series of reporter assays we
were able to show that E2F7 could inhibit E2F1-dependent proliferation markers and could
sensitise keratinocytes to subsequent differentiation stimuli. Based on these data we propose that
E2F7b is likely to be a physiologically-relevant regulator of the initiation of squamous
differentiation. We next went on to show that E2F7b was a potent suppressor of E2F1-induced
keratinocyte apoptosis. Combined, these data suggest that the antiproliferative, pro-differentiative
activity of E2F7 is consistent with a tumour suppressor function whilst the anti-apoptotic activity is
consistent with that of an oncogene. This situation is the opposite to that reported for E2F1. This
proposition takes on more significance when combined with our observation that E2F7b and E2F1
are highly expressed (10–100 fold) in human cutaneous squamous cell carcinomas (SCC).
Conclusions:
K E2F7 is likely to be a physiologically-relevant regulator of squamous differentiation.
K E2F7 may be oncogenic in the context of E2F;Rb dysregulation that occurs during SCC
formation
K E2F7 may contribute to SCC formation.
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Inhibition of MEK with AZD6244 is cytostatic as a monotherapy in melanoma, but
cytotoxic when combined with docetaxel leading to tumour regression in vitro
and in vivo
Nikolas K. Haass1,2, Katrin Sproesser2, Thiennga K. Nguyen2, Rooha Contractor2, Meenhard
Herlyn 2 and Keiran S.M. Smalley2
1Centenary Institute of Cancer Medicine and Cell Biology, Faculty of Medicine, University of
Sydney, Newtown, NSW and 2The Wistar Institute, Philadelphia, Pennsylvania, USA
Background: The highly aggressive and drug-resistant melanoma is the most common cancer of
young adults in New South Wales. The findings that the MAPK (Ras/RAF/MEK/ERK) pathway is
constitutively active in melanoma and that 66% of melanomas harbour the activating BRAFV600E
mutation has raised expectations for targeting this pathway for therapy. This study addresses the
anti-melanoma activity of the MEK inhibitor AZD6244.
Methods: We have developed a novel cell culture model where 3D melanoma spheroids are
implanted into collagen gels to mimic the tumour architecture and microenvironment. Here we
investigated the activity of AZD6244 in this 3D spheroid model in vitro as well as in vivo.
Results: In 2D cell culture, the drug was cytostatic and reduced the growth of melanoma cells in a
concentration-dependent fashion through induction of G1-phase cell cycle arrest. In our 3D
spheroid model the effects of AZD6244 were largely cytostatic and reversible, with drug washout
leading to re-growth. Growth inhibition was a direct effect on melanoma as there was no
significant inhibition of angiogenesis. 1205Lu cells were grown as tumour xenografts in SCID
mice. After tumour establishment (100mm3), mice were treated with AZD6244 orally, leading to
a decrease of phospho-ERK in the tumours and a significant suppression of tumour growth. The
original tumours remained viable, suggesting that AZD6244 monotherapy was largely cytostatic,
and not pro-apoptotic in this model. However, co-administration of AZD6244 (30mg/kg) with
docetaxel (15mg/kg) led to tumour regression.
Conclusion: For the first time, we show here an inhibitor that directly targets the MAPK pathway
in melanoma to correlate in vitro and in vivo data. AZD6244 fully inhibits growth at well-
tolerated doses in vivo and causes tumour regression when combined with docetaxel. The potent
effect of this MEK inhibitor/chemotherapy drug combination promises activity in the clinical
setting and a viable therapeutic strategy.
Inflammation of skin increases production of bone marrow CD11Cþ cells that
have reduced antigen presenting ability
P. Hart1, J. Lee1, S. Gorman1 and M Norval2
1Telethon Institute for Child Health Research, Centre for Child Health Research, University of
WA, Perth and 2University of Edinburgh, Scotland, UK
Background: Irradiation of skin with erythemal UV light reduces systemic immune responses to
antigens applied to non-irradiated sites. The effects of UV irradiation on numbers, phenotype and
function of antigen presenting cells derived from bone marrow ex vivo has not been previously
investigated.
Method: Mice were irradiated with a single high dose of UV, or multiple lower doses each
equivalent to a minimal oedemal dose. The effects of UV on bone marrow-derived cells were
compared to those of dorsally-applied 1,25 (OH)2 vitamin D3 (a product of UV irradiation of
skin), and of the inflammatory hapten, dinitrofluorobenzene (DNFB). Bone marrow cells were
cultured for 7 days with GM-CSFþ IL-4 before CD11cþ cells were purified from the non-
adherent cells. The CD11cþ cells were tested for their antigen presenting cell ability in vitro by
incubation at different ratios with CD4þ cells from ovalbumin-TCR transgenic mice plus the
ovalbumin peptide. Alternatively, CD11cþ cells were incubated with the soluble form of DNFB
for 30min prior to injection into the pinnae of ears of mice. After one week, the ears were
challenged with topical DNFB and after a further 24 hours, ear swelling measured.
Results: All skin treatments enhanced bone marrow cell yields. When bone marrow cells were
cultured under conditions optimized for dendritic cell development, greater numbers of CD11cþ
non-adherent cells were obtained from cultures derived from UV-irradiated or DNFB-treated
mice but not from vitamin D-treated mice. For the more inflammatory treatments (8 kJ/m2 UV,
0.5% DNFB), the antigen-presenting ability in vitro of these cells was significantly reduced and
remained less efficient after LPS activation (and the associated increase in CD86 expression) of
bone marrow-derived CD11cþ cells. With cell transfer, the ear swelling in mice that received
DNBS-loaded CD11cþ cells from UV-irradiated mice was consistently less than that in mice that
received DNBS-loaded cells from control mice.
Conclusion: These results suggest that skin inflammation can compromise the development of
dendritic cells in bone marrow for efficient Ag-presenting ability and contribute towards UV-
induced systemic immunomodulation.
Innate immunity in the skin is a layered molecular response system
Richard L. Gallo1
1Division of Dermatology, Department of Medicine and Paediatrics, University of California, San
Diego and VA San Diego Health Care System, San Diego, USA
Research efforts from several laboratories around the globe have defined gene-encoded systems
for the recognition of microbes and protection from infection. This so-called ‘‘innate immune’’
system has been defined as distinct from adaptive immune responses and is best understood in
terms of its speed since this system is the first to act in defence against infection. In skin, five
elements can be defined in first line defence against infection: the physical barrier, the
constitutive chemical barrier, a pattern recognition system, and inducible chemical response, and
a cellular recruitment response. The principles of this system are evolutionarily ancient but
remain critical to our understanding of human disease. Our group discovered the presence of
antimicrobial peptides in mamalian skin1 and has worked to understand the relevance of these
molecules in human disease. Peptides such as the cathelicidins are an important part of the
chemical barrier in the skin and their study has shown the importance of these molecules in the
overall immune network. For example, we have shown that targeted disruption of cathelicidin in
mice leads to an increase in the susceptibility to invasive bacterial infections2, and a change in
the capacity to recruit leukocytes following application of contact allergens3. In humans too little
antimicrobial peptide expression can explain the susceptibility of Atopic patients to infection4,
but too much antimicrobial peptide production can contribute to the pathophysiology of
Rosacea5 and Psoriasis6. Recent work from our laboratory has identified surprising mechanisms
for the control of skin immunity that involve the conversion of 25 OH Vitamin D to 1,25 OH
Vitamin D7, and a relationship between neuropeptides and protection against infection8 The rapid
progress seen in this field in the past five years has provided several new clues to better
understanding the elements involved in maintaining healthy skin and how failure of this system
results in disease.
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Murine epidermal langerhans cells and keratinocytes express the purinergic
receptor P2X7
R. Sluyter1,2; J. Tran2,3; S. Byrne4; R. Taylor3 and J. Wiley2
1School of Biological Sciences, University of Wollongong, Wollongong; 2Nepean Clinical
School; 3Faculty of Veterinary Science and 4Dermatology Research Unit, University of Sydney,
Sydney
Background: The purinergic receptor P2X7 is an ATP-gated cation channel important in
inflammation and immunity. We have previously demonstrated that human epidermal and
monocyte-derived Langerhans cells (LC), and human keratinocytes (KC) express functional P2X7
receptors (J Invest Dermatol, 125: 482, 2005). In this study, we examined whether P2X7 is present
in murine LC and KC, as well as in murine dendritic epidermal T cells.
Method: Three-colour flow cytometric measurements of nucleotide-induced ethidiumþ uptake
were used to determine whether P2X7 was present in epidermal cell suspensions prepared from
C57Bl/6 mice, as well as from P2X7 knockout and wild-type mice (C57Bl/6 background).
Results: ATP induced ethidiumþ uptake into LC and KC, with EC50 values of 516 and 447mM
respectively, but not into dendritic epidermal T cells. Various P2X7 agonists (BzATP 4 ATP
4ATPgS 4ADP) also induced ethidiumþ uptake into LC and KC, while agonists of other P2
receptors (UTP and ab meATP) were ineffective. NAD, which can activate P2X7 via ADP-
ribosylation in ART2.2þ cells, was also unable to induce ethidiumþ uptake into LC and KC,
despite inducing ethidiumþ uptake into murine lymphoid T cells. ATP-induced ethidiumþ
uptake in LC and KC was abolished in the presence of the P2X7 antagonist magnesium, as well as
in LC and KC from P2X7 knockout mice (but not wild-type littermate controls).
Discussion: Collectively, the above pharmacological and genetic data demonstrate that murine
LC and KC express P2X7. Therefore mice may provide suitable models to study the role of this
receptor in the skin immune system.
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Dermal dendritic cells, and not langerhans cells, play an essential role in inducing
an immune response
Scott N. Byrne1,2, Atsushi Fukunaga2, Noor M. Khaskhley2, Coimbatore S. Sreevidya2 and
Stephen E. Ullrich2
1Dermatology Research Laboratories, University of Sydney, NSW, Australia and 2Department of
Immunology and Center for Cancer Immunology Research, University of Texas, M.D. Anderson
Cancer Center, Houston, TX
Background: Langerhans cells (LCs) serve as epidermal sentinels of the adaptive immune system.
Conventional wisdom suggests that LC encounter antigen in the skin, and then migrate to the
draining lymph nodes, where the antigen is presented to T cells thus initiating an immune
response. Platelet-activation factor (PAF) is a phospholipid mediator with potent biological
effects. During inflammation, PAF mediates recruitment of leukocytes to inflammatory sites. Here
we tested a hypothesis that PAF induces LC migration.
Method and Results: Applying 2,4-dinitro-fluorobenzene (DNFB) to wild-type (WT) mice
activated LC migration. In contrast, applying DNFB to PAF receptor (PAFR)-deficient mice or mice
injected with PAF receptor antagonists failed to induce LC migration. Moreover, after FITC
application the appearance of hapten-laden LCs (FITCþ , CD11cþ , Langerinþ ) in the lymph
nodes of PAF receptor deficient mice was significantly depressed compared with that found in WT
mice. LC chimerism indicates that PAF receptor on keratinocytes but not LCs is responsible for LC
migration. Contrary to the diminution of LC migration in PAF receptor-deficient mice, we did not
observe any difference in the migration of hapten-laden dermal DCs (dDC ¼ FITCþ , CD11cþ ,
Langerin-) into the lymph nodes of PAF receptor-deficient mice. In addition, the contact
hypersensitivity response generated in WT or PAF receptor-deficient mice was identical. Finally,
dDCs, but not LCs isolated from the draining lymph nodes after hapten application activated T
cell proliferation.
Conclusion: These findings suggest that LC migration may not be responsible for the generation of
CHS, and dDCs may play a more important role.
The development of a quality of life instrument specific for pemphigus
S. Chee1,2, L.K Martin1 and D.F Murrell1,2
1Department of Dermatology, St George Hospital, Sydney and 2University of New South Wales,
Sydney
Background: Measurement of the impact of a disease on Quality of Life (QOL) is an important
outcome for evaluating effectiveness of care and for capturing aspects of patients’ health status
that may not correlate with clinical severity as assessed by dermatologists. Previous studies in
pemphigus have used the 36-Item Short-Form Survey (SF-36), which is a generic health measure,
and the Dermatology Life Quality Index (DLQI), which is broadly applied to measure QOL in all
skin diseases. A disease-specific measure, however, would be more sensitive in gauging changes
in QOL of pemphigus patients, especially since there is high morbidity from treatment.
Method: To develop the Quality of Life in Pemphigus (QOLIP) Questionnaire, non-structured
interviews were conducted with 25 patients for item generation. These patients suffered from
auto-immune bullous diseases including pemphigus vulgaris and bullous pemphigoid. In
addition, all dermatologists in New South Wales were sent letters inviting their patients to
contribute to the study. A focus group of pemphigus patients was then held to further check and
generate items. The items were then combined and reduced to form a pilot questionnaire with 45
items and compared with those generated from a previous study for epidermolysis bullosa
patients. The pilot questionnaire was distributed and completed by 16 patients.
Results: From the interviews, 88 items were recorded and reduced to 45 to form the pilot
questionnaire. Results from the pilot questionnaire were compiled and questions were retained or
deleted according to their impact and ability to discriminate between respondents. A final QOLIP
questionnaire with 25 items was formed. The QOLIP questionnaire is being distributed to a
broader group of pemphigus patients along with the DLQI, SF-36 and other standardized
measures of assessing function, depression and anxiety.
Conclusion: The items generated as affecting QOL in pemphigus patients are quite different from
those generated by a similar process performed for another blistering disorder, epidermolysis
bullosa, illustrating the importance of disease-specific QOL measures. Further evaluation of the
QOLIP should enable it to be used to monitor pemphigus patients in clinical trial settings and
improve their management.
A randomized controlled trial of autologous melanocyte transplanting with recell
vs minigrafting in chronic stable vitiligo
Supriya Venugopal1, Linda K. Martin1, Richard Wittal2, Lesley Rhodes1, Anna-Liza Agero1,
De´de´e F. Murrell1,3 and John Le Guay2
1Department of Dermatology, St George Hospital, Sydney; 2Vitiligo Clinic, Skin and Cancer
Foundation, Darlinghurst and 3University of New South Wales, Sydney, Australia
Background: Several techniques concerned with autologous melanocyte transplantation for
chronic stable vitiligo patients, with medically refractory vitiligo, are mentioned in the literature.
However there is a lack of controlled trials to determine and compare the efficacy of these
techniques. ReCell is an automated cell harvest device, which enables bedside preparation of a
non-cultured epidermal suspension. ReCell involves obtaining a split-thickness graft from normal
skin, processing into an epidermal cell suspension with the ReCell device and transplantation
onto to dermabraded skin. Mini-grafting involves transplantation of multiple 1.5mm full-
thickness punch grafts in a grid pattern and was used as the control.
Methodology:Our randomised controlled trial evaluated and compared the efficacy and safety of
mini-grafting and ReCell as surgical re-pigmentation techniques for chronic stable vitiligo. The
inclusion criteria were patients who had previously failed at least two medical treatments, had no
enlargement of patches for over 6 months and successfully underwent an initial pilot mini-graft
with 51.5mm full-thickness punch grafts, evaluated at 3 months. Mini-grafting and ReCell were
performed on each patient on randomised symmetrical vitiligo patches with dimensions of
4–10 cm2. The primary efficacy endpoint was percentage re-pigmentation at twelve months.
Secondary endpoints included colour match, blinded physician, patient-rated cosmetic outcome,
patient satisfaction, and quality of life.
Results: Pilot mini-grafts were performed on 25 patients. 17 patients had a positive response and 3
patients were withdrawn due to poor compliance. 12 patients reached six month evaluation.
Results were highly variable, with some patients achieving 100% re-pigmentation and others 0%
re-pigmentation at 6 months. There was no statistically significant difference in the efficacy
between ReCell and mini-grafting re-pigmentation, however when effective, a more uniform re-
pigmentation was observed with ReCell. Patients reported more post-operative pain of the Recell
site compared to the mini-grafting site.
Conclusion: Although the results of the study were variable, mini-grafting and non-cultured
epidermal suspension shows promising clinical utility in some patients.
Brm and Brg-1 protein expression is lost late in the progression of
non-melanoma skin cancer from benign to malignant
V. L. Bock1, J. G. Lyons1,2 and G. M. Halliday1
1Dermatology Research Laboratories, University of Sydney, Camperdown, NSW, Australia and
2Sydney Head & Neck Cancer Institute, Sydney Cancer Centre, Royal Prince Alfred Hospital,
Camperdown, NSW, Australia
Background: Although some of the early changes involved in the tumorigenesis of non-melanoma
skin cancer (NMSC) are already known, little is known about the late changes involved. We have
identified Brm and Brg-1 as important, previously unidentified putative tumour suppressors
involved in the progression of human actinic keratosis (AK) into cutaneous squamous cell
carcinoma (SCC). Brm and Brg-1 are mutually exclusive components of the SWI/SNF chromatin
remodelling complex. Chromatin remodelling is an essential process to enable access of the
appropriate cellular machinery to allow transcription of any gene or DNA repair. They have both
previously been found to be down-regulated at the protein and mRNA levels in a variety of
human carcinomas. However, neither has previously been implicated in human NMSC.
Methods: A total of 32 human SCC, AK and normal skin specimens were collected, snap frozen,
sectioned, and stained for the proteins of interest (Brm, Brg-1 and p53) using double-label
immunohistochemistry. Antibody specificity was confirmed by gene transfer experiments in cell
lines. Image analysis was performed using reproducible colour-based thresholding and the level
of each protein expression was quantified.
Results: The expression of Brm was dramatically reduced from the levels seen in normal skin and
AK at 61% and 66% of the epidermal area respectively, to 2% in SCC (Po0.001). A similar
reduction was observed for Brg-1, with an expression in normal skin and AK of 60% and 62%
respectively, reducing to 5% of the epidermal area of SCC (Po0.001). In contrast to this, p53
expression was reduced earlier in carcinogenesis, with a significant level of reduction occurring
between normal skin and AK specimens.
Conclusion:
Brm and Brg-1 are newly identified putative tumour suppressors, whose protein expression is
dramatically reduced in the progression of non-melanoma skin cancer from benign to malignant.
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Mechanisms of the photoprotective effect of 1a,25 dihydroxyvitamin D
V. Sequeira1 and R.S. Mason1.
1Discipline of Physiology, School of Medical Sciences and Bosch Institute, The University of
Sydney
Background: Ultraviolet radiation (UVR), specifically UVB, produces vitamin D3 from the
precursor, 7-dehydrocholesterol. There is substantial evidence that the skin contains all the
necessary hydroxylase enzymes to convert this inactive compound to the active hormone,
1a,25dihydroxyvitaminD3 (1,25D). Previous findings indicate a photoprotective role for 1,25D in
suppressing UVR-induced apoptosis and reducing UVR-initiated DNA damage, in the form of
cyclobutane pyrimidine dimers (CPDs). UVR on its own increases the activation of MEK/ERK and
JNK, however the effect of UVR on PI3-kinase is uncertain. The 1,25D-associated improvement in
cellular survival after UVR is dependent on intracellular pathways including, phosphatidylinositol
3-kinase (PI3-kinase), Raf/mitogen-activated extracellular signal related kinase kinase /extra-
cellular signal regulated kinase (MEK/ERK) and c-jun-N-terminal kinase (JNK). Whether these
kinases are also involved in the mechanism of protection against CPDs remains to be established.
Method: Keratinocytes were treated 24 hours prior to irradiation with 1,25D, an inhibitor of the
aforementioned cellular pathways or the combination of these. Cells were exposed to one
minimal erythemal dose of UVR and treated immediately following UVR. Thymine dimers were
detected by immunohistochemistry.
Results: Treatment of keratinocytes with the combination of 1,25D and PD98059 (inhibitor of
MEK activation) or LY294002 (specific inhibitor of PI3-kinase) reversed the protective effect of
1,25D against CPDs. Surprisingly, prevention of 1,25D-induced suppression of UVR-generated
JNK phosphorylation with SP600125 (this inhibitor of JNK signalling also reduces the 1,25D
suppression of JNK phosphorylation after UVR) did not alter the protective effect of 1,25D on
CPDs. Independent use of inhibitors of LY294002, PD98059 and SP600125 significantly
suppressed UVR-induced CPDs in the absence of 1,25D.
Conclusion: The MEK/ERK and PI3-kinase pathways are necessary for the reduction in CPDs after
UVR in the presence of 1,25D however, JNK phosphorylation is not critical to this mechanism.
Acne Rosacea and Vulgaris as an immune reconstitution inflammatory syndrome
(IRIS) in patients with HIV
VA.Preda1,2, LJ Leow3 and MJ Whitfeld1,2
1Department of Dermatology St Vincent’s Hospital, Sydney; 2The Skin & Cancer Foundation
Australia, Darlinghurst, Sydney and 3The Royal Children’s Hospital, Melbourne
Background: In the HIV-infected population, the introduction of highly active antiretroviral
therapy (HAART) has altered the pattern of dermatological disease. With the improvement of the
immune system on HAART, unmasking of a new skin disease or paradoxical worsening of existing
dermatological conditions frequently occurs, diagnosed as IRIS (Immune Reconstitution
Inflammatory Syndrome). IRIS usually presents within the first two months after the
commencement of HAART but can occur weeks to years later. One estimate places IRIS
involving the skin at half to three quarters of all IRIS event presentations.
We have noted the association of first presentations and flares of acne rosacea and acne vulgaris
in the setting of IRIS. Recent literature on the role of cathelicidin, a peptide found in rosacea,
suggests that the pathogenesis of rosacea can in part be explained by an exacerbated innate
immune response. Our observations in the setting of restored immunity with HAART are
consistent with this adding to the bulk of literature supporting the increasing recognition of the
spectral diversity of IRIS.
Methods: A retrospective case note review was performed of HIV-infected patients presenting to
St Vincent’s Hospital, Sydney; the Skin & Cancer Foundation Australia, Darlinghurst Sydney; and
the private consulting rooms of one of the authors from 1995–2007. Each patient’s record was
reviewed in relation to HIV diagnosis, HAART therapy, changing CD4 count and viral load. This
was then compared with the temporal association of exacerbated or newly presenting flushing,
erythema and pustules, clinically suggestive of rosacea or the new or exacerbated signs of acne
vulgaris. Past history of rosacea or acne vulgaris and prior treatment were also noted.
Results: We found that the time frame of patient complaint of new facial lesions consistent with
acne rosacea or acne vulgaris was 1–15months after commencement of HAART or regime
alteration to one more effective for T cell recovery.
Patients were responsive to trigger avoidance, standard topical and oral therapies for acne rosacea
and for acne vulgaris. Improved disease control was also noted after a prolonged period of
immune recovery ranging from months to a year.
Conclusion: It is important for clinicians to recognize that the development of rosacea-like signs
in the setting of HAART, is more likely to be rosacea occurring in the setting of immune
reconstitution, rather than a drug hypersensitivity or photosensitivity to one of the medications in
the HAART regime.
We hypothesize that given the temporal relationship between HAART and the development of
acne rosacea or acne vulgaris in our patients these conditions should be considered
dermatological manifestations of IRIS. These clinical presentations may also give us further clues
to the underlying pathological mechanisms involved in acne vulgaris and rosacea. The innate
immune system most certainly plays an important role in triggering inflammatory cutaneous
diseases.
Ultraviolet a within sunlight induces mutations in the epidermal basal layer of
engineered human skin
Xiao X. Huang1, Franc¸oise Bernerd2 and Gary M. Halliday1*
1Dermatology Research Laboratories, Melanoma and Skin Cancer Research Institute, The
University of Sydney, NSW 2006, Australia and 2L’Oreal Life Sciences Research, 92583 Clichy,
France
Background: Skin cancers are one of the most frequent human tumours. The ultraviolet B (UVB)
waveband within sunlight is an important carcinogen, however UVA is also likely be involved. By
ascribing mutations to being UVB or UVA induced, we have previously shown that human skin
cancers contain similar numbers of UVB and UVA induced mutations, and importantly the UVA
mutations were at the base of the tumours. To determine whether this occurred early or late
during photocarcinogenesis, and prove that the mutations were UV induced,
Method: We exposed engineered human skin (EHS) to UVA, UVB, or a mixture that resembled
sunlight. EHS resemble human skin, modelling differential waveband penetration to the basal
dividing keratinocytes, and the complex interplay between epidermal cells. Furthermore we only
gave 4 exposures with 0.25 of the dose of sunlight capable of causing sunburn in light skinned
Caucasians.
Results: Both UVA and UVB induced p53 mutations in over 90% of irradiated EHS, suggesting
that sunlight doses achievable during normal daily activities may contribute to skin cancer. UVA-
but not UVB-induced mutations predominated in the basal dividing keratinocytes that are thought
to give rise to skin tumours. Our studies also show that oxidative base damage may contribute to
both UVA and UVB mutagenesis but by different mechanisms. These studies indicate that UVA-
induces a larger number of mutations in dividing basal keratinocytes than UVB in the early stages
of photocarcinogenesis in human skin, UVA may be an important carcinogen during the early
stages of human skin cancer induction.
Conclusion: Suberythemal doses of both UVA and UVB can cause p53 mutations in EHS. The
results emphasise the need for greater public awareness that there are no safe UV wavelengths
Novel roles for melanoma tumour antigen P97 (melanotransferrin) in melanoma
cell proliferation and tumourigenesis
Y. Suryo Rahmanto1 and D.R. Richardson1
1Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales,
Australia 2006
Background:Melanotransferrin (MTf) is a membrane-bound transferrin homologue that binds one
atom of iron (Fe). The molecule is highly expressed on malignant melanoma cells and at lower
levels on normal tissues. However, the precise function of MTf remains unknown and is important
to understand considering its high expression in malignant melanoma.
Methods: Examination of the gene expression profile of five MTf expression models was
performed by whole-genome microarray analysis to understand the function of MTf. These
models included two stably transfected MTf hyper-expression models (i.e., SK-N-MC
neuroepithelioma and LMTK fibroblasts) and one cell type (SK-Mel-28 melanoma) where MTf
was down-regulated by post-transcriptional gene silencing. These findings were then compared to
the alterations in gene expression identified using the MTf / mouse (Sekyere EO et al. 2006
Blood 107:2599-601). In addition, the changes identified from the microarray data were also
assessed in a new model of MTf down-regulation in SK-Mel-2 melanoma cells. Clearly, this
comparative analysis had the potential to identify a function for MTf that is common to multiple
cell types and organisms.
Results: In the cell line models, MTf hyper-expression led to increased proliferation, while MTf
down-regulation resulted in decreased proliferation. Across all five models of MTf down- and up-
regulation, three genes were identified as commonly modulated by MTf. These included ATP-
binding cassette sub-family B member 5 (Abcb5), whose change in expression mirrored MTf
down- or up-regulation. In addition, thiamine triphosphatase (Thtpa) and transcription factor 4
(Tcf4) were inversely expressed relative to MTf levels across all five models. The products of these
three genes are involved in membrane transport, thiamine phosphorylation and proliferation/
survival, respectively.
Conclusions: In conclusion, these investigations identified novel molecular targets directly or
indirectly regulated by MTf and the potential pathways involved in its function, including
modulation of proliferation, migration and melanoma tumourigenesis.
Clinical outcomes of herlitz junctional epidermolysis bullosa infants: findings from
the australasian epidermolysis bullosa registry
Y.C. Kho1,2, S. Robertson3, I. Robertson4, A.L.C. Agero1, L.M. Rhodes1,2, G. Varigos3, J. Su3,
D. Orchard3 and D.F. Murrell1,2
1Department of Dermatology, St George Hospital, Sydney; 2The University of New South Wales,
Sydney; 3Royal Children’s Hospital, Melbourne and 4Mater Children’s Hospital, Brisbane
Background/Objectives: Junctional Epidermolysis Bullosa (JEB) is a rare inherited skin disorder,
characterised by blister formation at the level of the lamina lucida following minimal mechanical
trauma. Homozygous premature termination codon mutations in any of the LAMA3, LAMB3 or
LAMC2 genes lead to the degradation of the polypeptide products and give rise to the Herlitz
variant of JEB (H-JEB). H-JEB frequently manifests in early infant mortality due to excessive
mucocutaneous fragility and secondary bacterial infections. Extracutaneous disease activity also
affects a number of different organs and body systems. As yet, no data has been published in the
medical literature describing the Australasian experience of the disease.
Method: 10 infants with JEB-H were retrospectively identified from the recently established
Australasian EB Registry. The patient’s files were examined and, in addition, clinicians
responsible for the care of these infants were contacted for further data on clinical course,
complications, management, and outcomes.
Results: All 10 Herlitz JEB infants were deceased, with a mean age of death of 6.8 months (age
range, 2–13 months). Their recorded ethnicities were Caucasian, Lebanese and Chinese. Causes
and contributing factors of death were found to have been severe malnutrition, anaemia, failure to
thrive, electrolyte imbalances, sepsis, toxic shock, pneumonia, gastrointestinal haemorrhages and
multi-system organ failure. Complication rates have also been recorded within this cohort,
including data on skin, tracheolaryngeal, facial, oral, nail and genitourinary involvement.
Conclusion: Death for the majority of these infants occurred within the first year of life, most
commonly from bacterial sepsis and failure to thrive. Despite some infants undergoing
tracheostomy and gastrostomy, their clinical outcome failed to improve, as these procedures
did not resolve complications arising from the fragile internal mucosa. Hence, a non-
interventional approach had been adopted in the management of many of these patients.
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Immunotherapy for skin cancer
G. R. Leggatt1, J. Zhong1, S. Mattarollo1, X. Liu1, R. De Kluyver1, S. Fiorenza1, J. Zhou1,
U. Hadis1, N. Abdul Warif1, A. Rahimpour1, J. Broom1 and I. H. Frazer1
1Diamantina Institute, The University of Queensland, Brisbane, Australia
Background: Persisting infection of epithelial surfaces with some human papillomaviruses
conveys significant risk of epithelial cancers. Immunosuppression increases the risk of persisting
infection, but the mechanisms by which cell mediated immunity clears infection, and the reasons
why it sometimes fails to, are unclear.
Aim: To use a murine model in which skin expressing antigen as a transgene in keratinocytes is
grafted to an immunocompetent host to define mechanisms for clearance of keratinocytes
expressing non-self protein.
Results: Some non-self antigens invoke rejection of skin grafts expressing the antigen from a
keratin promoter, while others including the two transforming proteins of HPV, E6 and E7, do not.
Rejection requires CD8 T cells, is enhanced by CD4 T cells even in an antigen experienced host,
and is significantly enhanced by local inflammation. Promoters of T cell activation, and of antigen
presentation, and some cells of the innate immune system enhance priming to new antigen, and
rejection of grafts from an antigen experienced host. Anti-inflammatory cytokines constitutively
expressed in skin, and some cells of the innate immune system, suppress graft rejection, and their
inhibition or removal enables rejection of E7 expressing grafts.
Conclusions: The fate of keratinocytes expressing non-self antigen is determined by a balance
between pro- and anti- rejection regulatory forces in skin, and the balance affects not only
priming to new antigen, but the effectiveness of effector cells generated by previous priming or by
immunisation. Appropriate manipulation of the local immunological environment may therefore
assist immunotherapy targeted at HPV infected epithelium.
Hemidesmosomal collagen XVII enhances keratinocyte adhesion to collagen IV,
and in P38-MAPK-dependent migration and cell signaling
J.R. McMillan1,2, H. Qiao1, A. Shibaki1, H. A. Long1, G. Wang1, Q. Li1, W. Nishie1, R. Abe1,
M. Akiyama1 and H. Shimizu1
1Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
and 2Burns Research Group, Royal Children’s Hospital, Brisbane, Australia
Background: Collagen XVII (COL17), a transmembrane collagen, is thought to be involved in
keratinocyte adhesion and possibly migration, as COL17 defects disrupt keratinocyte-basal
lamina adhesion and underlie the disease non-Herlitz junctional epidermolysis bullosa (n-HJEB)1.
Methods: Using siRNA to knockdown COL17 expression in HaCaT cells, we assessed cell
characteristics including adhesion, migration and signaling.
Results: Control and siRNA transfected keratinocytes showed no difference in adhesion on plastic
dishes after incubation for 8 hours in serum-free keratinocyte-growth medium, however when
grown on collagen IV alone or BD matrigel (containing collagen IV and laminin isoforms) COL17
deficient cells showed significantly reduced adhesion compared to controls (Po0.01), and MEK1/
2 and MAPK demonstrated reduced phosphorylation in COL17 depleted cells. Furthermore,
COL17 deficient HaCaT cells plated on plastic exhibited reduced motility that was p38MAP
kinase dependent (after addition of the p38MAPK inhibitor SB203580). Conversely, keratinocyte
adhesion was independent of p38MAPK signaling.
Conclusion: Taken together, these results suggest COL17 has significantly wider signaling roles
than were previously thought, including the involvement of COL17 in keratinocyte adhesion to
collagen IV, in p38MAP kinase-dependent cell migration, and multiple cell signaling events
pertaining to MEK1/2 phosphorylation.
References
(1) McGrath, JA, Gatalica B, Christiano AM, Li K, Owaribe K, McMillan JR, Eady RA, Uitto J
(1995). Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal
transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa.
Nat Genet 11(1), 83–86.
Cell-polarity in tumour-infiltrating killer T cells promotes tumour rejection by
enabling escape from migratory restriction
P. Mrass1, I. Kinjo2, L. G. Ng1, Ellen Pure3, S. Reiner2, P. Vallotton4 and W. Weninger1,5
1The Centenary Institute for Cancer Medicine and Cell Biology, Newtown, NSW 2042, Australia;
2Abramson Family Cancer Research Institute and Department of Medicine, University of
Pennsylvania, Philadelphia, PA 19104, USA; 3The Wistar Institute, Philadelphia, PA 19104, USA;
4CSIRO Mathematical and Information Sciences, Locked Bag 17, North Ryde, NSW 1670,
Australia and 5Discipline of Dermatology, The University of Sydney, Camperdown NSW 2050,
Australia
Background/Methods: The immune system has the capacity to destroy tumours. Cytotoxic killer T
cells provide a major contribution to this process by directly engaging and killing individual
tumour- or tumour-associated cells. Notwithstanding, tumours frequently escape the immune
system, leading to progressive disease. The precise mechanisms behind the immune escape of
cancers are incompletely understood. Here, we tested the hypothesis that effective interstitial
migration of T cells within intact tumours is essential for tumor rejection. We used two-photon
microscopy to analyse the motility of wildtype killer T cells directly within intact tumours.
Furthermore, we generated effector T cells from mice deficient in CD44, which is a trans-
membrane molecule that has been shown to promote migration through its adhesive function.
Results: CD44 was crucial to sustain optimal interstitial migration of tumour-infiltrating T cells.
Strikingly, this effect was independent of its extracelllular domain, but mediated exclusively by
the intracellular domain. CD44-deficient cells failed to stabilize the ‘‘polar-complex’’, thus
causing a reduction of T cell-polarity. Computational analysis revealed that the reduction in T cell
polarity led to a lack of precision of the migratory machinery in CD44-deficient cells. This in turn
caused a reduced capacity of CD44-deficient cells ‘‘to stay on course’’ and increased numbers of
cells with restricted migration. Furthermore, we determined that this reduction in interstitial
migration led to impaired screening for target cells and an inferior anti-tumour response.
Conclusion: Our results provide evidence that interstitial migration of killer T cells can be
achieved primarily by cell-intrinsic mechanisms. These results unravel a novel immunologic
checkpoint that limits an effective execution of the effector phase of an immune response, and
provide new ground for the development of innovative anti-tumour strategies.
Connexin expression patterns in the epidermal tumour microenvironment of
melanoma are valuable biomarkers for diagnosis and prognosis
N.K. Haass1,2,3, D. Ripperger1, E. Wladykowski1, P. Dawson4, P.A. Gimotty4, C. Reich1,
F. Fischer5, P. Schmage5, I. Moll1 and J.M. Brandner1
1Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf,
Hamburg, Germany; 2Discipline of Dermatology, The University of Sydney, Sydney, NSW,
Australia; 3The Centenary Institute of Cancer Medicine and Cell Biology, Faculty of Medicine,
The University of Sydney, Newtown, NSW, Australia; 4Department of Biostatistics &
Epidemiology, Center for Clinical Epidemiology and Biostatistics, Abramson Cancer Center,
Philadelphia, PA, USA and 5Department of Restorative and Preventive Dentistry, University
Hospital Hamburg-Eppendorf, Hamburg, Germany
Background: Melanoma is the most aggressive, therapy-resistant and deadly form of skin cancer,
and has an increasing incidence, particularly in New South Wales where it is the most common
cancer of young adults. Novel complementary biomarkers for diagnosis and prognosis are
needed. Gap junctions are composed of connexins (Cx). They are essential for intercellular
communication and involved in proliferation, differentiation and homeostasis. Previously, we
showed that Cx26 and Cx30 are induced in the epidermal tumour microenvironment of skin
cancers including melanoma.
Methods: This study compares the extent of the Cx26, Cx30 and Cx43 expression in the
epidermal microenvironment of melanocytic nevi and melanomas and its association with
melanoma thickness, proliferative index of the tumour and its microenvironment, and with 5-year
metastasis/survival.
Results: The Cx26 and Cx30 induction in the epidermis adjacent to melanomas versus nevi was
highly sensitive and specific for melanoma (Cx26: 98%/93%; Cx30: 100%/71%). We found a
significant correlation of the vertical epidermal Cx26 and Cx30 dissemination and the horizontal
Cx26 dissemination with tumour thickness. Cx26 and Cx30 expression patterns significantly
associated with the proliferative index of the adjacent epidermis but not of the tumour.
Furthermore, horizontal Cx26 expression correlated significantly with metastasis, vertical Cx43
localization with 5-years survival.
Conclusion: Here we show for the first time a significant association between the progression of
melanoma and alterations in its epithelial tumour microenvironment. As melanomas but not nevi
influence connexin expression patterns in the epidermal tumour microenvironment significantly,
they are valuable biomarkers for diagnosis and prognosis.
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Skin cancer prevention: qualitative and quantitative research methods
J. K. Robinson Department of Dermatology, Northwestern Univ Feinberg School of Medicine,
Chicago, IL USA
Background: Clinical research often begins with a novel idea that is triggered when listening to a
presentation, participating in journal club, or reading a publication. The next step is framing the
hypothesis, searching the literature for similar work, discussing the hypothesis with colleagues
and modifying the hypothesis. Evolution of our skin cancer prevention research over a 20 year
period demonstrates the process.
Methods: In 1980, the phenomenon of patients with a nonmelanoma skin cancer (NMSC)
continuing deliberate tanning after Mohs surgical resection of a facial NMSC was identified. The
hypothesis was that a written and verbal educational sun protection intervention coupled with the
newly available sunscreen with an SPF of 15 or greater would change the sun protection behavior
of those contemplating change. The intervention was provided 2 weeks after surgery and
reinforced at subsequent clinical visits in 2, 6 and 12 months. Using the transtheoretical model of
change, the intervention and survey questions were developed in 3 focus group sessions of
patients. Then, the questions were tested among a cohort of 20 individuals for validity with
clinically observed pigment darkening in comparison to baseline photographs of the forearm, and
for reliability using test and re-test in 2 weeks. The intervention and self–reported outcome
measures were revised and repeated until subjects no longer wrote margin note comments about
the items. After the qualitative research was completed, the quantitative research was completed
from 1983–87 by enrolling a convenience sample of 1042 patients1.
Results: Sunscreen use was adopted by 62% of patients; however, 38% were noncompliant. A
random sample of the non-compliant patients participated in cognitive interviews that identified
the following attitudes: (a) Perception of health and attractiveness are formed as an adolescent
and young adult. (b) Adult skin cancer patients reported no subsequent change in these beliefs
formed in adolescence. (c) The belief that having a tan is attractive and a sign of good health
persisted despite having a facial skin cancer removed by Mohs surgery and educational
interventions.
Conclusion: Skin cancer incidence will be best influenced by engaging adolescents and young
adults; therefore. the research program evolved to include behavioral psychologists having access
to young adults on college campuses. In 2008, our group demonstrated that appearance focused
interventions reduced indoor tanning among college students2.
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Nanopatches for non-invasively targeting the skin: both delivery of biomolecules
and extraction for diagnostics
Kendall M Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of
Queensland
Folic acid and skin cancer
Murphy G Beaumont Private Clinic, Beaumont Hospital, Dublin, Ireland
An intra-patient, prospective study of topical Gentian Violet for the treatment of
chronic ulcers in non-Herlitz Junctional Epidermolysis Bullosa (nH-JEB)
S.S. Venugopal1, L.A. Intong1, H.I. Cohn1, J.Mather-Hillon1 and D.F. Murrell1,2
1Department of Dermatology, St George Hospital, Sydney, Australia and 2University of New
South Wales, Sydney, Australia
Introduction: Gentian violet (GV), a mixture of crystal violet and methyl violet is a dye belonging
to the di and triaminophenylmethanes class. GV has bactericidal and fungicidal properties. To
date, there have been no reports or trials of long term therapeutic use of GV in epidermolysis
bullosa. The logic for this trial was its antigranulomatous effects and ad-hoc suppression of
inflammation in an adult patient with nH-JEB. GV has anti-angiogenic properties via decreasing
ang-2 expression in vitro and Nox-2 and Nox-4 enzymes1.
Methods: An intra-patient comparative assessment of topical gentian violet treatment versus
conventional treatment (identical silicone dressings with crystacide) was performed in two
brothers of Afghan descent (EB-011 and EB-012) with nH-JEB. The brothers were aged 11 and 14
years and were monitored over five weeks. Wounds were photographed and measured using
Visitrak analysis. Pain, ooze and appearance were assessed using VAS scales and Quality of life
using DLQI and QOLEB2 tools.
Results: The relative reduction in ulcer size on GV treated legs was 36% & 27% for the EB-012
and EB-011 respectively. Stinging on the sites treated with GV was reported. QOL measures and
patient rated VAS scores did not show any significant change. There was a relative percentage
improvement in the Investigator VAS scores for EB-011 (16%) and EB-012 (30%).
The total wound size at baseline were 18.8 and 21.9 cm2 for control and GV treated legs for EB-
012 and 3.5 and 13.5 cm2 for EB-011 respectively. After 4 weeks of treatment, the total wound
size was 14.9 and 9.5 for control and GV treated legs for EB-012 and 4.2 and 12.5 for control and
GV treated legs for EB-011. The table below outlines the absolute and percentage reduction in
ulcer size in the two patients. Investigator VAS scores showed a 16% and 30% improvement for
EB-012’s control and GV treated legs. For EB-011, there was a 10% and 16% improvement in
investigator VAS scores for the control and GV treated legs respectively.
Conclusion: To date, there have been no randomized controlled trials investigating the efficacy
and safety of GV. GV may be a therapeutic option for ulcers in JEB patients and potentially for
other EB subtypes. A formal randomized controlled trial of GV in EB is recommended.
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Prognostic significance of different a6b4 Integrin immunolabelling patterns
at the dermal-epidermal junction in epidermolysis bullosa associated with
pyloric atresia
J.W. Frew1,3, P.J.H. Dopping-Hepenstal2 and J.A. McGrath3
1University of New South Wales, Sydney, Australia; 2The National Diagnostic Epidermolysis
Bullosa Laboratory, The Guy’s and St Thomas’ NHS Foundation Trust, London, UK and 3St John’s
Institute of Dermatology, King’s College London (Guy’s campus), London, UK
Background: Epidermolysis Bullosa with Pyloric Atresia (EB-PA) is characterised by a spectrum of
severity of mucocutaneous fragility, differing degrees of pyloric obstruction, and a highly variable
clinical outcome from death in infancy to mild disease with few signs and symptoms. Typically,
EB-PA is caused by mutations in the ITGA6 or ITGB4 genes that encode a6 and b4 integrins,
respectively. In contrast to other forms of EB, however, a paradigm for genotype-phenotype
correlation in EB-PA is lacking, and the interrelationship between skin biopsy findings, mutation
screening and clinical prognosis is unclear.
Methods: The aim of this study was to determine whether particular skin basement membrane
zone immunostaining patterns for a6b4 integrin could give insight into (a) the candidate gene, (b)
the nature of the pathogenic mutations, and (c) clinical prognosis. EB-PA case reports were
sourced from the literature from 1998–2008. Cases were included if they included skin
immunohistocehmistry results, information regarding phenotype, clinical course and outcome,
and mutation analysis. In addition, unpublished EB-PA cases from 1998–2008 were also added
from the UK National EB Diagnostic Laboratory (with the same inclusion criteria). A total of 29
cases were assessed in this study.
Results: Seven discrete patterns of skin labelling intensity were noted using antibodies to a6 and
b4 ntegrins. The most frequent finding (12/29 cases) was reduced intensity, but not a complete
absence, of labelling for both integrins. The finding of a complete absence of immunostaining for
either a6 or b4 integrin (with reduced intensity staining for the other integrin) or both integrins
(11/29 cases) was associated with failure to survive beyond 2 months of age. Presence of normal
or near-normal labelling intensity labelling for either a6 or b4 integrin (irrespective of whether the
other integrin showed reduced or absent immunostaining) (3/29 cases) was associated with a
better prognosis with survival for more than one year. No particular pattern of skin labelling
intensity was significantly associated with implicating a specific gene, mutation site or mutation
type. One exception to the emerging immunolabelling paradigm was a case resulting from
cysteine missense mutations in ITGB4. Skin from this individual (1 case) typically showed
reduced (but not absent) labelling for both a6 and b4 integrins (i.e. the most common pattern) but
prognosis was worse with death occurring within the first 3 months of life.
Conclusion: The use of immunofluorescence microscopy with antibodies to a6b4 integrin is able
to provide some prognostic insight in individuals with EB-PA. Nevertheless, in cases due to
missense mutations in critical cysteine residues, the clinical outcome is typically worse than the
immunolabelling pattern predicts for other EB-PA cases arising from different pathogenic
mutations.
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Advances in the clinical assessment of autoimmune bullous disease: the
development of a disease-specific quality of life instrument – the ABQOL
D. Sebaratnam1,3, S. Chee1,3 S. Venugopal1, L. Rhodes1, B. Welsh2 and D.F. Murrell1,3
1Department of Dermatology, St George Hospital, Sydney, Australia; 2Department of
Dermatology, St Vincent’s Hospital, Melbourne, Australia and 3University of New South Wales,
Sydney, Australia
Background: For many dermatological conditions, a measure of quality of life (QOL) provides a
suitable indicator to monitor disease activity, evaluate effectiveness of care and capture outcomes
of intervention. The literature puts forward that disease-specific instruments are the most specific
tools available in this domain, as they are most sensitive to changes in disease status. At present,
no disease-specific instrument exists for use in autoimmune bullous disease.
Method: Non-structured interviews were conducted with 26 patients suffering autoimmune
bullous diseases (AIBD) for item generation. A focus group was then held with additional patients
to generate and validate items. 88 items were combined and reduced to form a pilot quality of life
in autoimmune bullous disease (ABQOL) questionnaire with 45 questions, which was distributed
to 42 AIBD patients across Australia along with the Dermatology Life Quality Index (DLQI).
Results from the pilot questionnaire were evaluated and items were retained or deleted according
to their sensitivity and ability to discriminate between respondents. This enabled the development
of a preliminary ABQOL questionnaire consisting of 30 items. Further distribution of the pilot
ABQOL will enable a statistically sound final ABQOL questionnaire to be developed.
Results: Face and content validity were established by conducting in-depth, open interviews with
bullous patients as well as through review of the pilot ABQOL questionnaire by an expert in
bullous disease. Discriminative validity has been assessed qualitatively by reviewing the number
of insensitive items in the pilot ABQOL (15/45 [33%]) compared to the DLQI (8/10 [80%]),
through which the pilot ABQOL was found to be superior to the DLQI. Reliability was evaluated
by internal consistency, with the Cronbach alpha coefficient found to be 0.940, indicating
satisfactory reliability, particularly considering the pilot ABQOL spans a number of different
health-related dimensions.
Conclusion: The ABQOL questionnaire represents the first instrument developed specifically to
measure the quality of life for AIBD patients. Further AIBD patients are being recruited but
preliminary studies indicate the ABQOL will be a valid and reliable measure. Already, the pilot
ABQOL demonstrates some superiority to more generic QOL-instruments, such as the DLQI, as it
has been qualitatively shown to possess a greater sensitivity. It is hoped that the ABQOL will have
the potential to be used to monitor disease activity, foster a greater understanding of the burden of
bullous diseases and serve an end-point in clinical trials.
Discovery and development timeline of a novel treatment for actinic keratosis:
PEP005 (ingenol mebutate) Gel
G. Siller1, S. Ogbourne2, P. Welburn2 and J. Ramsay3
1Dermatology Research Centre, The University of Queensland, Brisbane, Australia; 2Peplin Ltd,
Brisbane, Australia and 3Mater Radiation Oncology, Mater Misericordiae Hospital, Brisbane,
Australia
Background: Actinic keratosis (AK) is a highly prevalent disease induced by chronic UV exposure
and represents the early phase of a disease continuum that can culminate in invasive squamous
cell carcinoma (SCC). Several therapies are available for AK, however their limitations, most
notably relating to prolonged treatment schedules, treatment-related pain or discomfort and poor
cosmetic outcomes, have stimulated interest in the development of new therapies. The sap of
Euphorbia peplus (E. peplus) has been used for centuries as a traditional remedy for various skin
conditions, including non-melanoma skin cancer (NMSC).
Methods: In 1999, an ethics committee-approved, open-design clinical trial was completed using
the raw sap of E. peplus to treat a range of difficult-to-treat NMSC and AK lesions. A total of 61
clinically or histologically diagnosed lesions were treated: 28 basal cell carcinomas, 16
intraepidermal carcinomas, 4 SCC, 12 AK. Treatment involved 3 consecutive days’ application of
the raw sap. Response rates were assessed clinically at varying intervals after completion of
treatment. The study was not powered to formally assess efficacy.
Results: One patient (1 lesion) was lost to follow-up. A complete clinical response rate (CCR) of
88% was observed for superficial lesions (mean 14-month follow-up) after 3 daily applications (6
lesions received a second course of 3 applications) of E. peplus sap. For AK, the CCR was 66%.
This trial confirmed anecdotal observations of the sap’s efficacy.
Conclusions: Following the results of this trial, further research using bio-activity guided
fractionation led to the identification of the active principle of E. peplus sap as ingenol mebutate
(PEP005), a multicyclic diterpene ester. The mechanism of action against skin cancer was
determined to be novel, involving a direct cytotoxic action (induction of necrosis) and the
recruitment of an innate immune response (characterized by antibody-dependent cellular
cytotoxicity). A formal development program for ingenol mebutate was initiated, which
established a suitable manufacturing process and drug product formulation, and culminated in
the filing of an Investigational New Drug application with the FDA in 2004. Between 2004 and
early 2009, 6 phase II clinical trials using ingenol mebutate gel were conducted in AK,
completing the phase II program.
In late 2008 and early 2009, data from 2 key clinical trials, PEP005-006 (trunk and extremities;
0.025% and 0.05% gel; n ¼ 222) and PEP005-015 (face and scalp; 0.005%, 0.01% and 0.015%;
n ¼ 264) showed that ingenol mebutate gel was well tolerated and resulted in the complete
clinical clearance of all treated lesions in 40–45% of patients following only 2 or 3 daily
applications.
Alternative complement pathway is a sensor of UVA-induced photodamage
G.M. Halliday1, D.L. Damian1, Y.J. Matthews1, M.P.F. Stapelberg1 and S.N. Byrne1
1Discipline of Dermatology, Bosch Institute, Sydney Cancer Centre, The University of Sydney,
NSW 2006, Australia
Both the UVB and UVA wavebands within sunlight are immunosuppressive in humans, with men
being more easily suppressed than women. UV can suppress both the induction of primary
immunity and reactivation of memory immunity. Our work has focussed on UV suppression of
recall contact and delayed hypersensitivity to nickel or tuberculin purified protein derivative.
Over physiological sunlight doses to which humans can be exposed during routine daily living or
recreational pursuits, both UVA and UVB suppress immunity. While there is a linear dose
relationship with UVB commencing at doses less than half of what is required to cause sunburn,
UVA causes a bell-shaped dose response over the range to which humans can be realistically
exposed. At doses too low for either waveband to be suppressive, interactions between UVA and
UVB enable immunosuppression to occur. At doses beyond where UVA is immunosuppressive, it
still contributes to sunlight-induced immunosuppression via this interaction with UVB. Our recent
studies using interference filters to determine the wavelength dependence in humans has shown
distinct non-overlapping immunosuppressive peaks at 300 nm UVB and 364–385nm UVA with
wavelengths from 310–350nm not being suppressive. Finding that it is high wavelength UVA that
is responsible for immunosuppression in humans was unexpected and indicates that this end of
the spectrum needs to be considered more carefully for impact on human health. As two distinct
UV wavebands are immunosuppressive in humans, this implies that different chromophores and
possibly mechanisms are involved. We have previously shown that these bell-shaped dose
responses to UVA are genetically restricted in mice, as they occur in C57BL/6 but not Balb/c
mice. We used gene set enrichment analysis of microarray data and real-time RT-PCR
confirmation to determine the molecular mechanisms associated with this UVA dose response.
We found up-regulation of mRNA for the alternative complement pathway. The core-enriched
genes complement component 3, properdin and complement factor B were all activated by the
immunosuppressive dose of UVA only in UVA-responsive C57BL/6 but not unresponsive BALB/c
mice. This therefore matched the genetic restriction and dose responsiveness of UVA
immunosuppression. This suggests that the alternative complement pathway is a trigger of
UVA-induced immunosuppression and that this pathway is likely to be an important sensor of
UVA-induced damage to the skin. Why alternative complement is activated with a bell-shaped
dose response is unknown, and the chromophore that leads to this is also unknown. UV
immunosuppression is an important health hazard to humans, and is clearly mechanistically
complex with UVB, UVA and interactive effects likely to be suppressive by different mechanisms,
and the mechanisms involved may even be dose dependent. It is only by understanding these
issues that we will be able to devise effective protective measures.
Suberythemal UV G2 phase checkpoint in response to post replication repair is
defective in a majority of melanoma cell lines
M. Wigan1, N. Giles1, S. Pavey1 and B. Gabrielli1
1Diamantina Institute, The University of Queensland, Brisbane, Australia
Background: The loss of cell cycle checkpoints is a major contributor to cell transformation and
genomic instability in cancers. Ultraviolet radiation (UVR) is a major environmental factor in the
development of melanoma and defects in mechanisms that respond to UVR damage in
melanocytes are major contributors to the development of melanoma. In human skin,
suberythemal UVR exposure has a mitogenic effect on the quiescent cells in the basal layer of
the epidermis and initiates a cell cycle checkpoint arrest in these cells as they progress into G2
phase. These are cells that were in G1 phase at the time of irradiation. We have established an
in vitro serum starved melanoma cell line model that mimics the mitogenic and G2 phase
checkpoint seen in skin to further characterize the mechanism of this G2 arrest. The majority of
melanoma cell lines we have investigated are defective for the G2 phase checkpoint arrest, which
may be a contributing factor in the development of melanoma. The UVR induced checkpoint is
p53 independent.
Methods: A2058 cells were synchronised using serum starvation and irradiated with 150 Jm2
UVB then harvested at times after irradiation. In some experiments cells were initially treated with
drugs or siRNA to selectively deplete specific proteins. Cells were analysed by FACS,
immunoblotting and immunofluorescence using specific antibodies. Neonatal foreskins were
maintained in minimal salt solutions and irradiated with 250 Jm2 and harvested at times after
irradiation for immunofluorescence staining.
Results: Cells overcome the arrest and progress into the subsequent G1 phase in the presence of
aphidicolin treatment, demonstrating they arrest in G2 and not S phase. Biochemical analysis,
siRNA knockdown and small molecule inhibitor studies indicate a role for the ATR / Chk1
signaling pathway but not ATM/Chk2 or p38 in this UVR checkpoint signaling. Analysis of UVR
induced DNA damage revealed that the majority of DNA lesions are rapidly repaired. XPA
depletion which inhibits nuclear excision repair initiate a strong S phase arrest, providing further
evidence that the G2 checkpint response was not a consequence of either unrepaired UVR
induced lesions. Imuunoflourescent staining showed RPA foci in G2 arrested cells that co-localise
with ATR, BRCA1 and gH2AX. Chromosome spreads of cells in which the UVR G2 checkpoint
was overridden showed a premature chromosome condensation phenotype which demonstrated
the presence of DNA damage. Comet assay was used to determine the DNA damage was ssDNA
and not dsDNA. Western blot showed a 7 kD band shift in PCNA in time points corresponding to
the G2 arrested cells indicating mono-ubiquitination of PCNA and a post replication repair
process. This same mechanism has been confirmed in neonatal foreskins in response to UVR.
Conclusions: The UVR induced G2 phase checkpoint response is a to post replication repair of
the few unrepaired UVR induced lesions that persist into S phase where replicative bypass of the
lesions creates a larger single stranded DNA gap which attracts the attention of the post
replication repair machinery, signaling both the G2 phase checkpoint arrest and repair of UV-
induced lesion, probably by the base excision repair pathway.
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Retrospective evidence on outcomes and experiences of pregnancy and childbirth
in epidermolysis bullosa in Australia and New Zealand
L.R.A. Intong1, S.D. Choi1, A. Shipman1, Y.C. Kho1,3, L.M. Rhodes1,3, M.G. Chapman2,3 and
D.F. Murrell1,3
1Departments of Dermatology and 2Women’s Health, St George Hospital, Kogarah, NSW,
Australia and 3University of New South Wales, Sydney, Australia
Background: The full impact of Epidermolysis Bullosa (EB) upon pregnancy has not been
comprehensively studied. We aim to develop a foundational database which can be used to
provide peri-obstetric advice in relation to EB, in the near future.
Methods: Survey questionnaires on pregnancy experiences were sent out to obstetricians, mothers
who had given birth to EB babies, and EB patients who had given birth. Results were analyzed.
Results:We received responses from 195 out of 1346 obstetricians surveyed, and only 14 of them
had encountered mothers or babies with EB. They all recommended normal vaginal delivery,
however, one performed an elective Caesarean section at the patient’s request, complicated by
poor healing and subsequent post-operative wound infection. We collated completed
questionnaires from 61 healthy mothers who had given birth to 78 children with EB. They
reported no more adverse events in their EB pregnancies compared to their non-EB pregnancies. A
further 30 female patients with EB (19 with EB Simplex, 1 with Junctional EB, 7 with Dominant
Dystrophic EB, and 3 with Recessive Dystrophic EB) who had given birth responded. Most had
normal vaginal deliveries. In general, there was no worsening of their EB during their pregnancy
and immediate peri-partum period, with just a few reports of nipple blistering during
breastfeeding.
Conclusion: Most patients with EB do not have an increased risk for pregnancy-related
complications. Awareness of this data amongst obstetricians and dermatologists should lead to
informed advice and improved quality of care for mothers and babies affected with EB alike.
UVR induced ERK signaling pathway regulates p16 expression in skin
N. Giles1, S. Pavey1 and B. Gabrielli1
1Diamantina Institute, The University of Queensland, Princess Alexandra Hospital, Brisbane,
Australia
Background: Ultraviolet radiation (UVR) and the familial melanoma susceptibility gene
p16INK4A on chromosome 9p21 are among the major risk factors which have been identified
to contribute to the development of melanoma. p16INK4A is found deleted in up to 30% of
primary melanoma and 480% of the melanoma cell lines. It encodes the protein, p16 which
functions as a negative regulator of cell cycle progression and a tumor suppressor. Exposure to
UVR can evoke a number of signaling events such as the JNK kinase, p38 MAP kinase and ERK
signaling pathways to regulate downstream effectors, which will in turn determine the final
cellular response such as proliferation, differentiation or apoptosis. Previous studies have
demonstrated that sub-erythemal doses of UVR induce the expression of p16 in both the in vitro
A2058 melanoma cell line model and physiologically relevant in vivo human skin model. This
study aims to give a better understanding of this UVR induced response by defining the
mechanism involved in regulating p16 expression.
Methods: A2058 melanoma cell line was synchronised in quiescence by serum starvation then
irradiated with 150 Jm2 UVB radiation. At time points after irradiation cells were harvested for
FACS and biochemical analysis of gene and protein expression. Human neonatal foreskins were
maintained in culture in minimal salt solution and irradiated with 250 Jm2 and harvested at the
indicated times for immunohistochemical and in situ hybridisation analyses.
Results: The data has demonstrated that the ERK signaling pathway is involved in regulating p16
expression, at both the transcriptional and translational level in both the cell line model and
human skin model. MiTF and JunB are two potential p16 transcription factors which have been
identified as being downstream effector targets of the ERK signaling pathway. Data from both
model systems has revealed that B-RAF, another melanoma susceptibility gene, is directly
involved the activation of ERK signaling to regulate p16 expression. We have also identified the
MiTF binding sites in the p16 promoter, but have found that the occupancy of these sites is
relatively unaffected by UVR. We are currently investigating whether the activity of MiTF is
increased through an ERK dependent mechanism.
Conclusions: Taken together, these results demonstrate that the melanoma risk factors, UVR and
melanoma susceptibility genes, p16, BRAF and MiTF are involved in a single biochemical
pathway. Further work is currently undertaken to further characterized the mechanism by which
ERK signaling is regulates p16 expression in the UVR response.
Visualisation of structural and molecular properties of the skin by multimodal
multiphoton microscopy
L.G. Ng1, J. Qin1, B. Roediger1, A. Smith1, P. Mrass1 and W. Weninger1,2
1The Centenary Institute for Cancer Medicine and Cell Biology, Newtown, NSW 2042, Australia
and 2Discipline of Dermatology, The University of Sydney, Camperdown NSW 2050, Australia
Background: Multiphoton (MP) laser microscopy represents a recently developed technique that
allows non-invasive deep tissue imaging. MP excited second (SHG) and third harmonic
generation (THG) microscopy is a powerful optical technique that combines different excitation
and emission techniques for three-dimensional (3D) reconstruction of biological specimens based
on non-linear optical and autofluorescent properties of tissues. In this study, we have developed a
MP laser microscopy imaging model that has allowed us to delineate the structural components of
normal skin.
Methods: Anaesthetized mice were placed onto a custom-built stage in order to position the ear
on a small metal platform for MP imaging. MP imaging was performed on a LaVision Biotec
TrimScope attached to an Olympus BX-51 fixed stage microscope equipped with water
immersion objective. The tissue was exposed to polarised laser light at wavelengths of 950 and
1150nm using a Titanium:Sapphire laser and an Optical Parametric Oscillator, respectively.
Images were analysed using Volocity software. Histologic sections were stained with antibodies
against collagen and elastin and imaged on the MP microscope.
Results: Intravital MP microcopy has enabled us to optically section through the entire ear skin,
i.e. from the epidermis down to the outer layers of the cartilage. We could identify major
anatomical components in skin tissue based on their autofluorescent signals. Thus, we observed
that SHG is most useful for the imaging of connective tissue, collagen fibers and striated muscles,
whereas THG allows imaging of elastin fibers. The identity of these structures was also confirmed
by examination of stained histological sections. In addition, we also show that when coupled with
MP fluorescence imaging, we were able to visualise lymphatic and blood vascular organisation in
the skin with high 3D resolution.
Conclusions: Collectively, these findings highlight the potential of multiphoton laser tomography
for the assessment of intrinsic molecular and structural changes of the skin related to various skin
diseases.
The effects of aging on phenotype and function of dendritic cells
S. Tan1, L. Cavanagh1, B. Fazekas de St. Groth1,2 and W. Weninger1,2
1Immune Imaging Laboratory, The Centenary Institute for Cancer Medicine and Cell Biology,
Newtown, NSW 2042, Australia and 2Discipline of Dermatology, The University of Sydney,
Camperdown NSW 2050, Australia
Background: Aging is associated with impaired immune functions leading to an increased
susceptibility to infections and cancer. While it is well known that aged individuals have a
general decline in adaptive immunity resulting, including decreased thymic output, a shrinkage of
the T cell repertoire and reduced activation of T cells, the effects on age on innate immune cells
remain largely uncharacterized. Here, we have investigated phenotype and function of dendritic
cells (DCs), the prime antigen presenting cells of the immune cells, in aged mice.
Methods: Dendritic cells were harvested from the spleens, skin-draining lymph nodes and
mesenteric lymph nodes of young (8 to 12 week-old) and aged (4 18 month-old) female C57BL/6
mice and analysed by flow cytometry. In addition, splenic DCs from these two groups of mice
were compared for their capacity to stimulate antigen-specific T cell proliferation in vitro.
Turnover of DCs was studied by exposing in the mice to BrdU in the drinking water.
Results: There was no significant difference between young and aged mice in the number of
dendritic cells in the spleen and lymph nodes. Aging also did not significantly alter the ratio of
CD8þCD11b- (lymphoid) and CD8-CD11bþ DCs (myeloid) in the spleen. The expression of
costimulatory molecules of the TNFR and B7 superfamilies (CD80, B7RP1, B7S1, B7H1, B7H4,
OX40 L, CD40, CD70) remained largely similar between young and aged DCs, except for
increased expression of CD86 on CD11cþMHC-IIþ DCs in the skin draining lymph nodes and
the spleen. In congruence with the phenotyping data, young and aged DCs showed comparable
antigen presentation capacity in vitro. Finally, proliferation of lymph node and splenic DCs
measured by BrdU uptake was similar in young and old mice.
Conclusions: Although known to affect various other immune functions, aging does not
significantly alter the phenotype and antigen presentation capacity of DCs.
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Molecular genetics of human pigmentation diversity
R.A. Sturm Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia
Variation in human pigmentation – skin, eye and hair colour – and skin cancer susceptibility, are
determined by genes that control melanisation. The discovery and characterisation of human
pigmentation genes combined with the study of these genes in melanocyte cell function have
provided a framework to understand normal variation in this physical trait and the associated risks
of melanoma formation. Melanin is formed via a biosynthetic pathway and packaged within a
specialised subcellular compartment termed the melanosome. Studies on the composition,
formation and function of the melanosome provides the key to comprehending diversity in human
pigmentation. The physical appearance of skin, hair and eye colour can vary dramatically among
geographically isolated human populations. It has long been speculated that this is due to
adaptive changes, but the genetic causes for this degree of phenotypic variation have remained
largely unknown. In the past decade my laboratory has isolated and characterised a number of
human pigmentation genes to use as tools to investigate gene regulatory mechanisms operating
within melanocytes, as well as allowing a combined genetic and cellular analysis of pigment
variation in populations with European ancestry. These genes include the enzymes encoded by
tyrosinase, tyrosinase-related protein-1 and dopachrome tautomerase (TYR, TYRP1 and DCT), the
P-protein (OCA2) and the melanocortin-1 receptor (MC1R). Variant alleles of the MC1R gene
resulting from a range of amino acid substitutions have been associated with red hair, fair skin, a
high degree of freckling as well as increased incidence of melanoma. Most recently we have
found a single SNP located in a regulatory region upstream of the OCA2 locus that determines
blue-brown eye colour inheritance in Europeans. Other population studies have revealed specific
polymorphisms within the MATP (SLC45A2) and NCKX5 (SLC24A5) protein coding regions
associated with the degree of skin pigmentation. Our studies take unique advantage of cultures of
human primary melanocytes derived from donor skin tissue and selected based on pigmentation
genotype and/or phenotype. Direct testing of a range of clonal melanocyte cultures characterised
for three causal SNPs within SLC45A2, SLC24A5 andOCA2 has assessed their impact on melanin
content and tyrosinase enzyme activity. From a culmination of genetic and functional studies it is
apparent that a number of genes impacting melanosome biogenesis or the melanin biosynthetic
pathway are candidates to explain the diversity seen in human pigmentation.
Induction of spheroid cultures from adherent melanoma cell lines to study the
heterogenous nature of melanoma tumours
E. Thurber1, E.C. Sturm1, G. Douglas1, J.H. Leonard2 and R.A. Sturm1
1Institute for Molecular Bioscience, University of Queensland Brisbane, Australia and 2Queens-
land Institute of Medical Research, Brisbane, Australia
Background: Tumour heterogeneity poses a major barrier to effective therapy and patient survival.
While the mechanisms necessary for generating subpopulations of heterogeneous melanoma cells
are yet to be theorised there is mounting evidence for three distinct cell phases in tumour
development. Expression profiles of specific markers indicate these phases to be (1) invasive cells,
(2) proliferative cells, and (3) melanoma initiating cells (MIC). Previous studies have shown that
melanoma cells grown under stem cell conditions as 3-dimensional spheroids have a more
invasive phenotype than their traditionally grown counterparts. The MIC cells which are capable
of reforming a tumour, may have gained their increased invasive potential due to the
microenvironment created by 3D culture. A comparison of the pathways regulating spheroid
cells and cells grown adherently may reveal some important regulatory differences, particularly in
regard to the cell heterogeneity seen within melanoma tumours, the transition between a growth
and invasive state, and the response to nutrient and oxidative stress. Differences in these pathways
may represent and important target for new cancer therapies.
Methods: In an attempt to characterise these different states, a range of long term adherent
melanoma cell lines were induced to grow as spheroids using embryonic stem cell growth
conditions to potentially enrich and isolate the MIC population. Protein expression of important
developmental and invasive pathways were compared in matched spheroid and adherent cultures
using immunoblotting and immunofluorescence techniques.
Results: Differences in protein and mRNA expression levels between adherent and spheroid cells
were found in markers for melanocytic stem cells, transcription factors and surface molecules.
The spheroids were found to be under oxidative and nutrient stress, as shown by necrotic cores,
and had heterogeneous protein expression correlating with a cell’s depth within the spheroid.
Conclusion: The spheroid cells are fundamentally different from their adherent counterparts as
shown by differential expression of proteins important in metastatic pathways. Further analysis is
needed to determine how the microenvironment created through these 3D spheroid culture
techniques affects the MIC expression profile and if metabolic stress is necessary for the transition
to the invasive state.
The role of MC1R in melanogenesis of melanocytic cells in co-culture with
keratinocytes
S.A. Ainger1, S.S. Wong1, D.W. Roberts1, J.H. Leonard2 and R.A. Sturm1
1Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia and
2Queensland Institute of Medical Research, Brisbane, Australia
Background: The melanocortin-1 receptor (MC1R) is highly polymorphic in the human
population, with over 80 variants so far described. Individuals with the coding region variants
R151C, R160W and D294H have been shown to be strongly associated with red hair, fair skin,
inability to tan, and increased risk of developing skin cancers (RHC phenotypes). Other low
penetrant variants such as V60L, V92M and R163Q have shown intermediate responses to UV
when compared to the full response of wild type MC1R and the defective high penetrant RHC
variants.
Methods: We have utilised clonal human melanocyte strains of defined MC1R genotype both in
monoculture and in a keratinocyte co-culture system using serum free conditions to compare
signalling of MC1R wildtype and variant receptors.
Results: Our studies revealed that the MC1R agonist NDP-MSH and cAMP activator forskolin
(FSK) both increased expression of DCT and dendricity of wild type MC1R melanocyte strains
using our co-culture system of human keratinocytes and melanocytes. The homozygote R variant
R151C showed no changes in expression of DCT in response to NDP-MSH, while R160W
showed decreased expression of DCT. A compound heterozygote R151C/R160W strain revealed
an intermediate DCT response to stimulation with NDP-MSH. The effect of stimulation on r
homozygote V60L variant strains with NDP-MSH showed reduced dendricity, while the V92M
homozygote variants expressed a vastly increased dendricity response even at basal control
levels. The pigmentation effects of wild type MC1R alleles and its signaling proteins were also
evaluated using the co-culture system. TYRP1, DCT, p38, phospho-p38 and phospho-p53
proteins were analyzed by western blotting, and mRNAs levels of Tyrosinase, TYRP1, and DCT
were analyzed by real time PCR. DCT protein expression was remarkably induced by NDP-MSH
and DCT mRNA was increased by more than 20-fold. Similar trends were seen using human
melanoblast strains in co-culture with keratinocytes. The induction of the phosphorylated form of
p38 in our co-cultures may contribute to the increased DCT protein expression and the roles of
p38 signaling in mediating the DCT transcriptional response is being investigated.
Conclusions: There were significant increases in DCT protein expression and cell dendricity in
MC1R WT melanocyte strains but not the RHC homozygous variants. DCT induction was
increased by NDP-MSH in both WT and the low penetrant strains, with the highest response
found with the V92M variant. TYRP1 and TYR expression was not significantly altered by
treatment with NDP-MSH or FSK. DCT was significantly increased in both mRNA and protein
levels in the co-culture system of melanocytes/melanoblasts and keratinocytes. Other pigmenta-
tion proteins and genes were not increased as markedly as DCT in both variants and WT.
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Skin-derived precursor cells fuse with differentiating myoblasts in vitro and home
to injured muscle following systemic delivery in vivo
M.C.S. Lee1,3,4, M. Kita2,3, A. Quigley2,3,5, A. Macintyre3,4, N.W. Rufaut1,4, R.M.I. Kapsa2,3,4,5
and R. Sinclair1,4
1Department of Dermatology, St Vincent’s Hospital, Fitzroy, VIC, Australia; 2Intelligent Polymer
Research Institute, University of Wollongong, Wollongong, NSW, Australia; 3Centre for Clinical
Neurosciences and Neurology Research, St Vincent’s Hospital, Fitzroy, VIC, Australia;
4Department of Medicine (SVHM), The University of Melbourne, St. Vincent’s Hospital, Fitzroy,
VIC, Australia and 5Bionic Ear Institute, East Melbourne, VIC, Australia
Background: Skin-derived precursors (SKPs) are multipotent cells that arise spontaneously in cell
cultures derived from the dermis. The plasticity of SKPs has been demonstrated by their
differentiation into neurons, glia, and adipocytes1. Dermal papilla cells and dermal fibroblasts
have been shown to be capable of myogenic differentiation in vitro2,3 and in vivo4. Side
population cells from the epidermis have been reported to home to sites of muscle injury
following intravenous injection5. In contrast, neither the myogenic potential nor the in vivo
homing ability of SKPs have been previously described. We have therefore investigated the
possibility of using intravenously injected SKPs as a cell therapy for muscle injury.
Methods: SKPs were isolated from the dorsal skin of 129S46T (ROSA26) mice, which
constitutively express b-galactosidase and which express dystrophin protein in differentiated
muscle tissue. To assess their myogenic potential in vitro, SKPs were co-cultured with
differentiating myoblasts from b-galactosidase-negative C57Bl/6 mice. To investigate homing
capability in vivo, we first injected notexin into the left gastrocnemius muscle (LGM) of male
C57BL10/JDMD/ mice, which do not express dystrophin protein. Notexin induces local muscle
injury and a subsequent regenerative response. We then injected 100,000 SKPs into the tail vein
to determine whether they could home to the injury site and participate in myo-regeneration. The
LGMs were collected two weeks after SKP injection and stained for b-galactosidase and
dystrophin expression.
Results: When myoblasts alone differentiated in vitro, they fused together to form multinucleated
myotubes, but did not stain for b-galactosidase. SKPs maintained alone in the same conditions did
not form myotubes. However when SKPs were co-cultured with differentiating myoblasts, some of
the multinucleated myotubes that formed did stain for b-galactosidase. Thus the SKPs had
participated in the differentiation process by incorporating into nascent myotubes. When SKPs
were intravenously injected into notexin-treated mice, b-galactosidase staining was observed to
localize to the injury site in the LGM. Similar results were obtained for seven of eight repeats. No
b-galactosidase was detected in the uninjured right gastrocnemius muscles of the same mice.
These results show that injected SKPs had migrated to the muscle injury site. However
immunohistochemical analysis suggested that they had not undergone myogenic differentiation.
In contrast to injected myoblast controls, dystrophin expression was not detected in muscles
engrafted with ROSA26 SKPs. Thus although the SKPs homed to the muscle injury site, they did
not then form myofibers and participate in muscle repair in vivo.
Conclusion: This is the first demonstration that SKPs can incorporate into myotubes, and that
systemically administered SKPs can home to sites of muscle injury. Given the relatively low
number of SKPs injected, the homing of even a few cells to the muscle injury site represents a
promising, novel approach to cell-mediated remodelling of muscle. The discrepancy between the
myogenic potential shown by SKPs in vitro and their lack of myo-regenerative activity in vivomay
result from compromised interaction between SKPs and endogenous myoblasts in the more
complex environment of injured muscle. Future studies should address the optimization of both
the culture environment used to prepare cells and the in vivo delivery procedures, in order to
enhance the interaction of SKPs with endogenous myoblasts following homing.
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Cultured ovine dermal papilla cells reproduce the dermal condensation stage of
hair follicle development
N.T. Goldthorpe1, N.W. Rufaut2, O.A.M. Wallace1 and A.J. Nixon1,2
1AgResearch, Ruakura Research Centre, Hamilton, New Zealand and 2Department of
Dermatology, St Vincent’s Hospital, Melbourne, Australia
Background:Hair follicles form in embryonic skin through a series of epithelial-mesenchymal cell
interactions involving Wnt, BMP, and FGF signalling events (1,2). A critical stage is dermal
condensation, leading to the formation of the dermal papilla (DP) and induction of hair growth.
This morphogenetic process determines the patterning and size of cutaneous structures and is
thought to be recapitulated in adult follicle cycling and disrupted in hair growth disorders. DP
cells retain some ability to aggregate when grown in vitro (3), however, the extent of aggregation
can be variable and this behaviour is generally lost with continued culture (4). We have observed
stable aggregation throughout extensive culture of DP cells isolated from sheep. These aggregates
form well-developed papilla-like structures. We hypothesise that this property of ovine DP cells
represents aspects of developmental morphogenesis. Our aim here was to test the effect on the
size of aggregates of perturbing growth factor signalling pathways which are thought to underlie
morphogenesis in vivo.
Methods: Intact DPs were dissected from wool follicles from the neck skin of sheep. Cells were
grown from DP explants in a medium of MEM with antibiotics and 20% lamb serum. Stocks of
cells were propagated for 2 or 3 passages and then stored frozen for later experiments. The effect
on aggregation of the following variables was determined:
K Growth until senescence under either subconfluent or aggregating conditions.
K Coating of culture substrates with type I collagen, fibronectin or laminin.
K Addition to the medium of small molecule inhibitors: lithium chloride (GSK3 inhibitor; Wnt
agonist), dorsomorphin (BMP inhibitor), or SU5402 (FGF inhibitor).
K Addition to the medium of minoxidil sulphate in combination with lithium chloride.
Cultures were fixed and stained, and aggregate size was measured by image analysis. Aggregate
diameters were compared using heteroscedastic Student’s t-tests.
Results: Doubling times were 20 hours for DP cells maintained in subconfluent cultures, and 42
hours for cells plated at high density and allowed to aggregate. Both retained robust aggregative
behaviour until beginning to senesce after approximately 90 cell doublings. Cells formed
aggregates on all substrates tested, but the propensity to aggregate was greater on fibronectin and
collagen compared to uncoated plastic. Aggregates formed readily on laminin but were smaller
than on other substrates. These results are consistent with requirements for cell attachment to
components of the extracellular matrix. Addition of growth factor agonists or antagonists to the
media produced non-linear dose response effects, e.g. 20mM LiCl, 1 mM dorsomorphin, and 30mM
SU5402 reduced aggregate diameter to 0.18 (P40.001), 0.55 (P40.001), and 0.52 (P40.01)
times that of untreated cells, respectively. The miniaturisation of DP aggregates induced by 10mM
lithium chloride was abolished by 40 mM minoxidil; an effect consistent with the clinical treatment
of balding patients.
Conclusion: We have demonstrated for first time that the size of DP cell aggregates in culture is
responsive to manipulation of morphogenetic growth factors, as well as to minoxidil (5). These
results show the potential of the ovine DP culture system as an experimental model for hair
morphogenesis. We have optimised culture conditions and image analysis procedures in a
bioassay for pharmacological effects on papilla size. This could provide a useful tool for
investigating critical mechanisms which underlie follicle formation and hair growth disorders.
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The expression of aquaporin3 in the pilosebaceous unit of mammalian skin is
consistent with a role in hair production
N.M. Edwards1 and P.I. Hynd1
1Animal Science, School of Agriculture, Food and Wine, The University of Adelaide, Roseworthy
Campus, South Australia, Australia
Background: Aquaporins are a family of membrane channel proteins involved in the regulation of
fluid and small molecule (glycerol, urea and nitrate) transport across epithelia and endothelia.
Aquaporin3 (AQP3) is a co-transporter of both water and glycerol and has been found to be
expressed in the basal layer of epidermal keratinocytes where it is involved in cell migration,
hydration of the stratum corneum, wound repair and skin elasticity (1). There have been no
detailed reports of AQP3 localisation to the hair follicle or the associated glands (sebaceous and
sudoriferous). One might expect that AQP3 could influence a number of key events in
pilosebaceous function, including proliferation and migration of the germinative follicle bulb
cells, dehydration of the keratinising cortical cells of the hair fibre, hardening of the inner root
sheath cells and energy metabolism in sebocytes and cells of the follicle. We aimed to determine
if aquaporin3 was present in the various compartments of the pilosebaceous unit.
Methods: Skin biopsies were collected from rats during anagen, catagen and telogen phases of the
hair cycle. Midside and leg skin was collected from a Merino sheep to yield follicles from different
stages of the hair cycle. Skin was also collected from the midside of a marsupial macropod, the
Tamar wallaby (Macropus eugenii eugenii). Skin was fixed for 2hrs in buffered formalin, stored in
70% ethanol and then processed, paraffin-embedded and sectioned at 8 mm. The skin sections
were deparaffinised and brought to water. Antigen retrieval was achieved by incubating the slides
in sodium citrate buffer at 951C. A standard avidin-biotin immunohistochemical protocol was
then applied using a rabbit polyclonal primary antibody directed against aquaporin 3 protein
(AQP3 H-80; sc-20811 from Santa Cruz Biotechnology Inc, USA) and a biotinylated anti-rabbit
IgG secondary antibody. Nova red was used as the detection substrate. Negative control slides
were treated as above but with no primary antibody.
Results: AQP3 expression was evident in the epidermis, sebocytes and epithelial cells of the
sweat glands of all three mammals studied. Endothelial cells and erythrocytes in dermal blood
vessels also stained positively for AQP3. AQP3 was clearly evident in the anagen hair follicle.
Cells of the follicle bulb and the migrating fibre were strongly stained in the proximal part of the
follicle. The dermal papilla was negative for AQP3 expression. The dermal connective sheath was
also negative while the outer root sheath was positive for AQP3 protein throughout its entire
length. In the proximal follicle the inner root sheath stained positive for AQP3 in all three layers
but the Henle’s layer ceased to express AQP3 earlier than the other layers at a point coinciding
with its early hardening. The Huxley and cuticle layer of the inner root sheath also became
unstained at the point at which they cornify and corresponded to the level at which the fibre and
medulla become fully keratinised and cease to stain for AQP3. The site and level of expression of
AQP3 changed throughout the hair cycle. During catagen the dermal papilla became positive for
AQP3 and staining in the germinitive bulb cells increased. In telogen the outer root sheath
remained positive for AQP3 but the staining was reduced in intensity and the rounded dermal
papilla was strongly, positively stained.
Conclusion: AQP3 is strongly expressed in cells of the follicle and the associated appendages and
is conserved across three mammalian species. The changing expression pattern throughout the
hair cycle and the location of expression within the pilosebaceous unit, suggest that AQP3 may be
involved in keratinisation and terminal differentiation of cells of the fibre and inner root sheath.
These processes require dehydration and regulated water transport. We also speculate that AQP3
could be involved in provision of glycerol as a metabolic fuel for the rapidly dividing follicle bulb
cells and sebocytes for mammalian fibre and sebum production.
1Hara-Chikuma, M. & Verkman, A. S. (2008). Roles of aquaporin-3 in the epidermis. J Invest
Dermatol. 128(9), 2145–51.
Reversible miniaturisation of the hair follicle: a role for the arrector pili muscle
A. Yazdabadi1,2, D. Whiting3, N. W. Rufaut2 and R. Sinclair1,2
1Department of Dermatology, St.Vincent’s Hospital, Melbourne and 2University of Melbourne;
3The Hair and Skin Research and Treatment Centre, Dallas, Texas
Background: Hair follicle miniaturisation is involved in several disease processes.1,2,3 The role of
the arrector pili (AP) muscle in miniaturisation and its reversibility has been largely overlooked.
We hypothesise that the maintenance of attachment of the secondary vellus hair to the AP muscle
determines its ability for reversible miniaturisation. The exact mechanism for this requires further
investigation
Method: We studied three dimensional reconstructions from three disease processes, male and
female pattern hair loss which are of gradual onset and largely irreversible1 and alopecia areata
(AA) which is of sudden onset and has the potential for complete reversibility and a control of
diffuse alopecia1.
Results: In both male pattern hair loss (MPHL) and female pattern hair loss (FPHL) which are
largely irreversible there was no attachment of the AP muscle to the miniaturised hair. In
comparison in AA which is potentially completely reversible the vellus hair maintained its
attachment to the AP muscle.
Conclusion: We provide preliminary evidence for the possible role of the arrector pili muscle in
the reversibility of hair follicle miniaturisation. The exact mechanism for this is not clear.
However our hypotheses include a source or stem cells or an interaction with the stem cell
population of the bulge area. Further studies are needed to evaluate the role of the arrector pili
muscle in the reversibility of hair follicle miniaturisation.
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NOXA inhibits melanoma growth and invasion in 3D models
N. Mohana-Kumaran1, K.M. Lucas1, W. Weninger1,2, J.D. Allen1 and N.K. Haass1,2
1Centenary Institute of Cancer Medicine and Cell Biology, Faculty of Medicine, University of
Sydney, Newtown, NSW, Australia and 2Discipline of Dermatology, University of Sydney,
Sydney, NSW, Australia
Background: Melanoma is the most aggressive, therapy-resistant and deadly form of skin cancer,
and has an increasing incidence, particularly in New South Wales where it is the most common
cancer of young adults. Novel anti-melanoma therapeutics are urgently needed. BH3-mimetics
inhibit the anti-apoptotic proteins BCL2, BCL-XL and BCL-w. In vitro and pre-clinical studies have
shown that it is active against lymphoid tumours but, in general, not solid tumours. This has led to
some re-evaluation of the significance of BCL2 as a therapeutic target in many cancers. It is clear
that sensitivity to the drug is related to expression of another BCL2 relative, MCL1, that is
unaffected by the drug, and also by expression of the pro-apoptotic BH3-only protein NOXA,
which inhibits MCL1. The aim of this study was the characterization of the consequences of over-
expression of NOXA or knockdown of its antiapoptotic target MCL1 in melanoma.
Methods: As preclinical studies in vitro often poorly predict the outcome of clinical studies, we
have previously developed a novel cell culture model which better compares to the in vivo
situation: melanoma cells grown as three-dimensional spheroids are implanted into collagen to
mimic tumour architecture and microenvironment. The use of intravital multi-photon microscopy
allows in vivo real-time imaging of the interactions of melanoma cells with their microenviron-
ment. Here we discuss the consequences of NOXA over-expression or MCL1 knockdown in our
novel 3D spheroid model and a xenograft model.
Results: We show that NOXA over-expression dramatically sensitised melanoma cells to a BH3-
mimetic (4100-fold) and other cytotoxic drugs in 2D cell culture in vitro. Moreover, NOXA over-
expression delayed the growth of melanoma cell line xenografts. MCL1 knockdown had similar,
although weaker, effects. Using 3D melanoma spheroids implanted in collagen gels, we observed
that NOXA over-expression slows spheroid growth, inhibits invasion into the collagen gel matrix,
and hypersensitises to the BH3-mimetic, reinforcing and to some extent explaining the xenograft
results. Thus, NOXA expression, by inhibiting MCL1, appears to affect the growth, invasiveness
and drug sensitivity of melanomas.
Conclusion: An unresponsive intrinsic apoptosis pathway has long been regarded as a factor in
the drug resistance of melanoma. Our in vitro results confirm that NOXA and MCL1 levels are
major determinants of sensitivity to interventions that target components of the intrinsic apoptosis
pathway. For the first time we show here that elements of the intrinsic apoptosis pathway also
exert a strong influence on the growth and invasiveness of melanoma cells in 3D models in vitro,
and on engraftment and growth of melanoma xenografts.
Kit signalling in melanoma and the melanocyte proliferative response to UVR
G. Walker1, B. Gabrielli2, N. Box3, K. Takahiro4 and H. K. Muller5.
1QIMR, Brisbane, Australia; 2Diamantina Institute, Brisbane, Australia; 3University of Colorado,
Denver, CO, USA; 4Gifu University, Gifu, Japan and 5University of Tasmania, Hobart, Australia
Background: Precisely how ultraviolet radiation (UVR) initiates malignant melanoma (MM) is
debated. The widespread view is that MM emanates from melanocytes (MCs) carrying unrepaired
DNA damage. We believe that this may not necessarily be so for all MMs. As a model to study the
influence of sun exposure on MM development we have used neonatal UVR to induce
melanocytic lesions in various transgenic mice. MM develops in these animals after a single
exposure, giving us the opportunity to study the actual insult that ‘‘initiates’’ the neoplastic
process. Despite the specialised nature of the murine system, it is likely to yield important
information about basic mechanisms of MC transformation following sunburn in humans. The
effectiveness of neonatal UVR may depend upon the muted response of neonatal skin to UVR due
to its developmental immaturity. Our studies point to another possible explanation: that neonatal
UVR is effective because neonatal MCs exhibit a greatly enhanced propensity to proliferate in
response to UVR-induced DNA damage.
Methods: Neonatal mice (3-day-old) were given a single exposure from a bank of 6 Phillips UVB
lamps (total UVB dose — 5.9 kJ/m2, erythemally-weighted — 1.8 kJ/m2). Pups were sacrificed at
multiple time points after UVR and skin sections stained with various antibodies by
immunofluorescence.
Results: In neonatal skin we observed a surprising UVR-induced MC migration to the epidermal
basal layer that did not occur in adult mice. At 3d post UVR, when most DNA damage was
repaired, dendritic MCs were visible at the dermo-epidermal junction, their numbers peaking at
around 5d, then diminishing over time. This MC response was completely inhibited by treatment
with the Kit receptor-blocking antibody, ACK2. The epidermal MCs appear to migrate from the
hair follicles via the outer root sheath (ORS) in response to paracrine signals from damaged
epidermal keratinocytes. Our results are suggestive of activation of Kit-positive/Tyrosinase-
negative ORS MC precursors. MCs in MM-prone mice removed pyrimidine dimers at least as
efficiently as wild type, so a repair defect cannot explain their increased susceptibility to UVR
transformation. Surprisingly, epidermal MC count after UVR in animals carrying an activated
Cdk4 was no greater than that for wild type. It was very low in p53-null mice, indicating that the
MC proliferative response is largely p53-dependent.
Conclusions:Murine neonatal MCs are exquisitely sensitive to UVR-induced stimuli during the only
developmental period when mice are susceptible to MM ‘‘initiation’’ by UVR. With embryonic
MCs migrating downwards (under ‘‘growth’’ stimuli) into developing hair follicles, it represents a
critical window when the MC’s fate as hair bulb MC or bulge MC stem cell is determined. Neonatal
MCs essentially behave as transit amplifying cells (i.e. highly proliferative) except that they emanate
from the embryo rather than adult MC stem cells. We are assessing whether, after neonatal UVR,
ORS MCs simply reverse their trajectory and migrate upwards (under ‘‘wound’’ stimuli), or whether
a dormant ORS population is activated. In either scenario, localisation of MCs in the ORS and the
basal layer is highly reliant upon p53-dependent upregulation of Kitlg by keratinocytes and its
subsequent stimulation of the MC Kit receptor. KIT-driven MC proliferation and migration are
inextricably linked to ‘‘tanning’’ (a protective response) in mammals. But activating KIT mutations
are seen in MMs associated with chronic sun exposure, suggesting that its upregulation is important
in some cutaneous melanocytic lesions. Thus the MC proliferative response may be a ‘double-
edged sword’. On one hand, it helps increase skin pigmentation to shield against subsequent
damage. On the other hand, in certain circumstances, such as for cells carrying a Ras mutation,
sustained UVR-induced stimulation may prime MCs for transformation. A second critical point
concerns the origin of the migrating follicular MCs. We are investigating whether they emanate
from bulge MC stem cells or other ORS precursors. These MCs may be important not only as part of
a UVR response, but also in the development of some forms of MM, with early lentigo maligna
MMs often having satellite hyperpigmented dots (corresponding to hair follicles) surrounding the
main lesion. We propose that activation of the same population of follicular MCs explains the
‘‘spotted’’ repigmentation that is often observed in vitiligo, due to activated ORS MCs migrating
upwards and then radially outwards into the epidermis.
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Re-programming of mature pigment-producing melanocytes to multipotent adult
stem cells through activation of Notch1 signaling
S.E. Zabierowski1, R. McDaid1, B. Himes1, M. Fukunaga-Kalabis1, L. Li1, S. Patel1 and M. Herlyn1
1The Wistar Institute, Philadelphia, Pennsylvania, USA
Melanocytes originate from migratory neural crest cells that emerge from the neural plate during
embryogenesis. Among other neuronal derivatives, these neural crest cells give rise to committed
unpigmented melanoblasts that home to specified destinations where they ultimately differentiate
into mature pigment-producing melanocytes. Notch signaling plays a paramount role in this
process by maintaining survival of melanoblasts and melanocyte stem cells though inhibition of
apoptosis. However, upon melanocytic maturation, signaling via Notch wanes as mature
pigmented melanocytes lack activated Notch. Given the importance of Notch in melanocyte
development, we questioned whether reactivation of Notch signaling could de-differentiate
melanocytes toward a precursor state. We show that ectopic expression of intracellular Notch1
(NIC) alone can reprogram melanocytes toward a primitive neural crest stem-like cell by driving a
cascade of de-differentiation. Notch overexpressing melanocytes formed spheres in stem cell
media, akin to neuro- and mammospheres, that resulted in the downregulation of mature
melanocytic markers including S100,gp100 and TYRP1, whilst concurrently upregulating neural
crest stem cell-related markers p75, Sox10, Snail, Slug and Twist. Unlike iPS cells, however, NIC-
infected melanocytes did not re-activate expression of Nanog, SSEA-3 or other markers associated
with pluripotent embryonic stem cells. Reminiscent of the migratory nature of primitive neural
crest stem cells, NIC-infected melanocytes were also highly motile when embedded into 3D
collagen matrices and in vitro human artificial reconstructed skin. Additionally, these re-
programmed melanocytes acquired the ability to self-renew, as well as differentiate into multiple
functional mesenchymal and neuronal lineages. Collectively, these results suggest that mature
melanocytes cells can be reprogrammed towards a primitive neuronal adult stem cell through the
ectopic activation of Notch signaling. The clinical relevance of these observations could be
instrumental in regenerative and/or replacement applications where the accessibility of ES cells
and overall understanding of iPS cells is still limited.
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